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ABSTRACT 
 Female breast cancer (FBC) is the most common invasive cancer among women of all 
races and ethnicities in the United States (US). We aimed to estimate FBC burden in 
Missouri in terms of FBC incidence, mortality and survival rates; visualize these results; 
and assess the usability of the Missouri Cancer Registry and Research Center’s (MCR-
ARC’s) interactive maps. 
FBC survival data were calculated from 2004 to 2010 after matching MCR’s FBC cases 
with Missouri death records, Social Security Death Index (SSDI), and National Death 
Index (NDI) database. FBC incidence and mortality rates were measured from 2008 to 
2012.  Survival and incidence data were measured by age, race, stage and grade at 
diagnosis and by senate district. Mortality data was measured by age, race, and by county 
and senate district grouped to county boundaries (SDGCs). The rates were visualized 
using InstantAtlas™ software. A scoping review and a two-round usability testing study 
were conducted to explore perceptions of public health professionals about the use of 
geographic information systems and to assess the usability of the MCR-ARC’s published 
maps.  
The dissertation results could be very informative for Missouri decision makers and 
public health leaders. The visualized data could enhance communication between 
collaborators from different fields related to FBC and inform health professionals and the 
public.  
Keywords: Breast cancer, incidence, mortality, survival, MCR, MCR-ARC, NDI, SSDI, 
Usability. 
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Introduction 
In the United States (US), about 12 percent of women will be diagnosed with breast 
cancer at some point in their lives [1]. Nationally, the estimated new cases of breast 
cancer was 14 percent of all new cancer cases and the estimated deaths from breast 
cancer in 2014 was 7 percent of all cancer deaths [2]. The dissertation includes three 
main projects. 
Dissertation’s Main Projects 
The First Project:  
The investigators measured and visualized accurate female breast cancer (FBC) incidence 
and survival rates through a secondary analysis of FBC cases in the Missouri Cancer 
Registry (MCR)’s database from 2008 to 2012 for FBC incidence and from 2004-2010 
for 5-year FBC survival. They measured FBC mortality for the period 2008-2012 using 
mortality data from the National Vital Statistics System (NVSS) database maintained by 
the National Center for Health Statistics (NCHS).  
Traditionally, incidence and mortality rates have been presented in data tables, a format 
that is easily understood by epidemiologists and statisticians, but one that does not meet 
the needs of all potential users of the data. Data visualization is an alternative means of 
portraying the burden of breast cancer at various levels (e.g., county, regional, state, etc.) 
There is a critical need to build accurate fact sheets in the form of interactive and 
dynamic map reports of the breast cancer burden at the sub-state level in Missouri.  
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The investigators measured breast cancer incidence, mortality and survival rates using 
innovative methodology. To obtain survival rates, the investigators augmented linkage 
with Missouri death files, obtained from the Missouri Department of Health and Senior 
Services (DHSS) Bureau of Vital Statistics, by linking cases with unknown vital status or 
cause of death following this linkage with Social Security Death Index (SSDI) and 
National Death Index (NDI) data; the latter is administered by the National Center for 
Health Statistics (NCHS). NDI is considered the best resource to obtain death status and 
cause of death for unmatched cases that may have been diagnosed in one state but died in 
another state, thereby leading to more accurate survival rates [3]. The investigators also 
measured FBC mortality-to-incidence ratio (MIR) to explore cancer age and racial 
disparities in Missouri by SDGCs. The investigators presented the dissertation’s results 
using interactive mapping software that builds dynamic reports of maps and statistics to 
improve data visualization [4].  
The Second Project:  
The investigators also conducted a scoping review study to assess perceptions and 
preferences of public health professionals and policy makers about the use of geographic 
information system (GIS) technology in public health research and policy.  
The Third Project:  
The investigators assessed the usability of MCR’s published interactive reports. These 
reports include cancer and other contextual indicators’ data at the Missouri county level. 
The investigators chose to study the usability of MCR’s published maps to assess the 
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need for modifying and simplifying existing maps and apply the same methodology to 
future MCR-designed visualized reports. 
How the Three Dissertation Projects Are Related 
The dissertation’s three main projects are methodologically different but the three 
projects’ outcomes are very connected. The three projects shared the same mission and 
vision regarding FBC in Missouri. The dissertation investigators measured the FBC 
burden in Missouri and visualized the results, using a specific methodology and 
technology, as interactive mapping reports. To make the MCR’s reports, which display 
the most accurate cancer and other contextual results very informative and 
understandable to the reports’ potential users, these reports should undergo extensive 
usability assessment and evaluation using pilot samples of those actual users.  In addition 
to the usability study of two rounds, which was conducted for this dissertation, the 
investigators tried to assess the preferences and perspectives of the mapping reports’ 
actual users in the public health field using previous GIS usability literature for the years 
from 2000 to 2016 to write a scoping review. By conducting the two-round usability 
study and the review, the investigators have had comprehensive ideas and hints on how 
they improve the published MCR maps’ usability and they were able to anticipate the 
perception and the predilections of the reports’ actual users. 
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Estimate and Visualize Female Breast Cancer Incidence Rates in 
Missouri Senatorial Districts in Interactive Mapping Formats,  
2008-2012 
Abstract 
Objectives: To measure and interactively visualize female breast cancer (FBC) incidence rates in 
Missouri by age, race, stage, grade, and senate district of diagnosis from 2008 through 2012.  
Methods: The FBC cases in counties split by senate districts were geocoded. A population 
database was created and a database was created within SEER*Stat. The incidence rates and the 
95% confidence intervals (Cis) were age standardized using US 2000 Standard Population. The 
U.S. Census Bureau’s Cartographic Boundary Files were used to create maps showing Missouri 
senatorial districts. Incidence results were loaded, along with the maps, into InstantAtlas™ 
software to produce interactive reports. We compared District 19 and Missouri’s incidence data 
and conducted an incidence data comparison between District 19 and the combined districts 20 & 
30. 
Results: The area profile and double map interactive maps, including maps, graphs, and tables 
for the 34 Missouri senatorial districts, were built. For all races and ages, District 19’s FBC 
incidence rates were higher than Missouri’s rates. The FBC incidence rate among women >50 
years old in district 19 was higher than the Missouri rate. The FBC incidence rates for whites and 
African Americans were higher within District 19 than Missouri. FBC incidence for African-
Americans in District 19 was significantly higher than Missouri. FBC incidence data by late stage 
and grade percentages for District 19 were lower than Missouri’s incidence percentages. FBC 
cases in District 19 tended to be diagnosed in situ or at an early stage (i.e., local); these cases are 
successfully treatable and seldom proceed to FBC late stages (i.e., regional and distant). 
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Therefore, the incidence pool of the late-stage incidence rates was lower in District 19 than 
combined districts 20& 30 and Missouri. For both studied regions, FBC incidence rates did not 
have a consistent pattern of differences by age or race. 
Conclusion: The results may provide an estimation of social inequality within the state. Results 
could provide clues about the impact level of coverage and accessibility to screening and health 
care services has on disease prevention and early diagnosis.  
Keywords: Female Breast Cancer, Incidence, InstantAtlas™, Interactive Maps, Missouri, 
Senatorial Districts 
Introduction 
Breast cancer incidence rates could be increased by increasing the intensity of breast 
cancer screening measures and interventions. These rates might be decreased by 
increasing prevention measures for cancer risk factors [1].  
The central cancer registry database is a high quality controlled source to estimate the 
epidemiological rates because it follows very strict, regularly updated measures and 
standards [2]. Many studies revealed that there are inequalities between cancer cases 
according to age, race, and stage and grade at diagnosis variables [3, 4, 5, 6, 7, 8, 9].  
Numerous evidence-based studies have concluded that the use of interactive geographic 
mapping software could allow users to interact easily with the data sets and help to 
publish high quality interactive reports. Distribution of geospatial health data could help 
public health leaders and decision makers in designing, developing, and adopting 
effective and efficient strategies and programs to improve public health outcomes by 
targeting the heavily affected geographical areas with the visualized health event [10, 11, 
12]. 
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The aims of the current study were: 1) To measure female breast cancer (FBC) incidence 
rates in Missouri from 2008 to 2012 according to the FBC cases’ age at diagnosis, race, 
and Senate District of diagnosis. 2) To visualize the measured incidence rates in 
InstantAtlas™ interactive mapping reports. 3) To compare spatial variances and potential 
disparities in incidence data between some senate districts and Missouri.  
Methods 
The study’s design was an observational, epidemiological study. The investigators did 
secondary analysis of all FBC cases in the Missouri Cancer Registry (MCR) database 
from 2008 to 2012.  
The calculated incidence rates were age-standardized using US 2000 Standard Population 
for comparability across regions with differing age structures. We calculated the 95% 
confidence interval (CI) for these rates using SEER*Stat statistical package [13]. The 
investigators compared the calculated Missouri demographic and geographical incidence 
rates using the same statistical package. The FBC cases in counties split by senate 
districts were geocoded to determine their district for incidence; obtaining the 
denominator for districts with split counties presented a challenge. The investigators used 
TIGER/Line® Shapefiles and TIGER/Line® Files to geocode these FBC cases [14].  
Population data at the district, age, race, and year level for these cases was created by 
combining Census American Community Survey (ACS) and Population Estimation 
Program (PEP) data. A database was created in SEER*Stat, a statistical software package 
for analyzing cancer data. Variables were created and imported to aid analyzing MCR’s 
FBC in SEER*Stat. The Census Bureau’s Cartographic Boundary Files were used to 
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create maps showing Missouri counties and state senatorial districts [15]. Incidence 
results were loaded along with the Cartographic Boundary Files into the InstantAtlas™ 
software to produce interactive mapping reports that display our study’s results. We will 
attach our interactive mapping reports to the MCR-ARC website. The interactive reports 
included maps, graphs, and tables for the 34 Missouri senatorial districts.  
The senatorial district assignment process included all FBC cases in the MCR database 
diagnosed from 1996 through 2012 who were residents of Missouri at diagnosis. The 
final analysis and maps only included the FBC cases diagnosed from 2008 through 2012 
with a known county of residence 
The current article involves in detail the results for the comparison between District 19 
and Missouri’s incidence data, and the incidence data contrast between District 19 and 
the combined districts 20 & 30. 
District 19 includes Columbia, which is the largest city in the Columbia Metropolitan 
Statistical Area (MSA). We compared the measured FBC incidence data of District 19 to 
the combined districts 20 & 30, which includes the city of Springfield, the largest third 
city in Missouri according to the 2010 US Census. The compared districts are not entirely 
alike in demographic structure and in rural-urban fraction. By conducting this contrast, 
we matched the FBC incidence data of two minor metropolitan areas in Missouri. Both 
areas embrace university campuses -- the University of Missouri-Columbia and the 
Missouri State University in Springfield -- and are mostly urban with very small rural 
fractions. We presumed that a large fraction of these areas’ population have easy access 
to FBC screening services and we assumed that the diagnosed FBC cases from both cities 
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are cases of low grades and stages and tend to be managed and monitored for better 
cancer outcomes. 
Statistics based on a small number of cases are suppressed to help protect confidentiality. 
As commonly used by MCR-ARC and other central cancer registries, a threshold of five 
was utilized. 
We tested if the regions’ differences were statistically significant by determining the 
overlap of the 95% CIs of the compared FBC incidence rates. 
Results 
The senatorial districts’ incidence rates of FBC were classified, as shown in tables 1-3, 
along with the following variables: All malignant FBC cases, less than 50 years old FBC 
cases, 50-64 years old FBC cases, 65+ years old FBC cases, white race FBC cases, 
African-American race FBC cases, late stages FBC cases, and high grade FBC cases. The 
tables contain the incidence rates for all the senatorial districts and Missouri and the 95% 
confidence intervals of the measured incidence data for all the above-mentioned 
variables.  
Table 1. Female Breast Cancer (FBC) Incidence Rates across Different Age Groups of 
Females in Missouri 
Senatorial 
Districts 
<50 Years Old  50-64 Years Old  65+ Years Old  
Rate LL UL Rate LL UL Rate LL UL 
1 46.2 38.8 54.6 284.9 252.8 320.1 509.4 461.1 561.4
2 45.4 38.5 53.1 304.5 267.8 344.9 483.3 425.4 546.8
3 36.4 29.6 44.4 276.5 242.3 314.2 410.4 363.6 461.6
4 44.1 36.7 52.7 283.6 249.5 321.1 508.7 457.5 563.9
5 39.5 32.3 47.8 278.7 242.4 319.0 475.0 413.6 543.0
6 42.4 35.0 51.0 232.6 202.0 266.5 403.0 357.9 452.1
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7 42.2 34.8 50.6 270.3 236.0 308.1 464.4 409.2 524.9
8 40.5 33.7 48.3 273.0 239.5 309.8 392.1 340.8 449.0
9 41.1 33.7 49.6 305.4 268.4 346.1 468.3 415.0 526.4
10 41.7 34.6 49.9 268.4 235.1 305.1 412.7 364.1 465.8
11 35.5 28.6 43.7 256.8 222.8 294.5 417.8 371.4 468.2
12 43.0 35.6 51.5 252.0 220.3 287.0 392.7 349.5 439.7
13 46.5 39.2 54.7 314.6 278.5 354.0 436.0 387.9 488.3
14 54.9 46.5 64.4 330.0 293.0 370.3 437.9 387.9 492.5
15 51.1 43.5 59.8 326.0 292.8 361.9 544.7 494.5 598.6
16 38.0 30.7 46.3 236.5 205.5 270.8 419.0 372.4 469.8
17 42.1 35.1 50.1 296.3 260.5 335.7 469.1 414.5 528.8
18 42.2 34.5 51.0 263.1 230.4 299.1 407.0 364.0 453.6
19 41.9 34.4 50.4 281.6 245.5 321.5 492.3 432.4 558.1
20 42.5 35.4 50.5 276.1 242.8 312.7 395.5 348.8 446.8
21 36.7 29.9 44.7 254.9 222.2 291.1 385.6 341.5 433.8
22 44.4 37.2 52.6 237.0 205.8 271.5 373.3 321.6 431.0
23 47.4 39.8 56.0 299.2 265.8 335.6 430.1 379.4 485.7
24 47.1 39.4 55.9 295.3 263.3 330.2 542.6 494.0 594.6
25 39.8 32.5 48.2 225.3 195.4 258.6 363.2 322.7 407.3
26 44.2 37.0 52.3 323.9 289.9 360.7 461.3 413.1 513.5
27 44.5 36.9 53.3 239.5 208.1 274.4 371.8 329.2 418.4
28 33.9 27.2 41.7 264.8 232.8 299.9 391.0 350.6 434.7
29 32.7 26.3 40.1 193.3 166.6 223.0 408.3 366.5 453.7
30 41.2 33.5 50.2 292.8 256.1 333.3 435.9 388.5 487.4
31 43.2 35.8 51.7 256.3 223.9 292.1 409.6 364.4 458.7
32 33.2 26.8 40.7 205.2 176.4 237.3 339.3 298.4 384.2
33 31.2 24.7 38.8 194.3 166.6 225.4 346.6 306.9 390.0
34 41.4 34.5 49.4 260.1 227.8 295.7 404.2 355.7 457.4
Missouri 41.9 40.6 43.2 268.9 263.1 274.8 428.0 419.6 436.5
 
Table 2. Female Breast Cancer (FBC) Incidence Rates among White and African-
American Females in Missouri 
Senatorial 
Districts 
White Race Black Race 
Rate LL UL Rate LL UL 
1 141.5 131.6 152.0 176.8 121.7 248.1
2 139.1 128.4 150.6 152.9 86.8 247.0
3 119.7 110.3 129.9 ^ ^ ^ 
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4 139.6 126.9 153.2 135.4 119.0 153.5
5 134.9 116.9 154.9 131.1 116.8 146.5
6 116.6 107.2 126.6 106.3 50.1 193.2
7 129.5 117.8 142.2 131.9 108.5 158.9
8 120.1 110.1 130.9 132.3 81.6 201.1
9 120.0 103.9 138.1 146.1 132.3 160.9
10 121.4 111.7 131.8 142.2 86.3 219.7
11 117.5 107.6 128.1 116.9 79.8 164.6
12 118.0 108.8 127.8 ^ ^ ^ 
13 133.1 119.0 148.6 139.8 125.0 156.0
14 145.2 128.6 163.5 144.3 130.2 159.5
15 155.6 145.5 166.4 100.8 42.3 201.8
16 117.9 108.3 128.1 66.1 26.3 138.9
17 136.2 125.6 147.6 99.8 52.2 171.0
18 120.6 111.1 130.6 186.0 114.3 284.1
19 132.0 120.6 144.2 175.5 126.6 235.7
20 123.5 114.0 133.7 ^ ^ ^ 
21 114.6 105.3 124.6 87.9 46.5 151.0
22 115.3 105.5 125.8 ^ ^ ^ 
23 134.4 124.1 145.4 147.8 90.3 228.5
24 153.8 142.7 165.5 132.0 102.4 167.5
25 108.7 99.6 118.6 101.2 72.7 136.9
26 140.2 130.3 150.7 84.3 32.8 198.6
27 115.2 105.8 125.3 128.4 82.2 190.3
28 111.8 103.1 121.0 ^ ^ ^ 
29 104.9 96.6 113.8 ^ ^ ^ 
30 130.4 119.9 141.5 78.4 33.4 152.5
31 121.1 111.6 131.2 117.3 53.4 220.5
32 99.4 90.8 108.6 ^ ^ ^ 
33 96.1 87.8 104.9 ^ ^ ^ 
34 120.3 110.6 130.6 105.8 60.4 170.4
Missouri 123.8 122.1 125.6 134.8 129.4 140.5
^: Incidence statistics based on a small number of new cases are suppressed to help 
protect confidentiality. As commonly used by MCR-ARC and other central cancer 
registries, a threshold of five (5) was utilized. 
Table 3. Incidence Rates of All Malignant, High Grade, and Late Stage Female Breast 
Cancer (FBC) in Missouri (2008-2012) 
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Senatorial 
Districts 
All Malignant 
High Grade (III + 
IV) 
Late Stage 
(R+D) 
Rate LL UL Rate LL UL Rate LL UL 
1 43.7 39.9 47.8 28.0 25.1 31.2 29.3 26.6 32.1 
2 34.7 30.8 39.0 27.8 24.4 31.4 28.9 25.9 32.1 
3 50.8 46.4 55.5 37.5 33.6 41.6 33.4 30.0 36.9 
4 50.3 45.9 55.0 34.3 31.0 37.8 29.6 26.8 32.6 
5 54.1 48.8 59.8 46.9 42.5 51.3 38.6 34.9 42.3 
6 42.1 38.3 46.3 29.2 25.6 33.1 24.4 21.4 27.5 
7 38.0 34.0 42.4 32.9 29.2 36.8 30.0 26.9 33.3 
8 38.0 33.9 42.5 33.2 29.3 37.2 29.1 25.9 32.5 
9 51.7 46.9 56.8 38.0 34.1 41.9 36.1 32.7 39.5 
10 44.5 40.3 48.9 24.2 20.8 27.7 29.5 26.2 32.8 
11 44.4 40.3 48.9 29.1 25.4 32.9 33.8 30.4 37.4 
12 45.5 41.6 49.7 33.7 30.0 37.5 31.1 27.9 34.5 
13 48.6 44.2 53.3 36.6 33.0 40.2 32.5 29.5 35.6 
14 50.6 46.0 55.6 42.4 38.7 46.1 32.2 29.2 35.2 
15 46.2 42.3 50.4 29.9 27.0 32.9 26.3 23.9 28.8 
16 45.6 41.4 50.0 35.5 31.5 39.5 33.5 30.1 37.1 
17 42.7 38.3 47.3 31.2 27.6 34.9 30.0 26.8 33.3 
18 52.4 48.2 56.9 29.6 26.1 33.3 31.0 27.9 34.3 
19 40.9 36.4 45.7 31.9 28.1 35.9 25.5 22.3 28.8 
20 36.4 32.6 40.5 37.4 33.7 41.3 27.4 24.4 30.6 
21 46.1 41.9 50.5 32.4 28.6 36.4 34.1 30.7 37.7 
22 44.9 40.2 50.1 35.0 30.9 39.2 29.6 26.2 33.2 
23 40.5 36.4 44.9 30.5 27.1 34.0 31.2 28.2 34.4 
24 40.3 36.7 44.1 30.7 27.7 33.8 26.2 23.7 28.8 
25 52.8 48.5 57.4 35.1 31.2 39.2 34.5 31.0 38.2 
26 39.7 36.0 43.8 32.0 28.8 35.3 25.5 22.9 28.3 
27 43.1 39.2 47.3 36.2 32.3 40.2 30.7 27.3 34.2 
28 42.7 39.1 46.7 41.7 37.9 45.6 33.1 29.9 36.4 
29 39.8 36.2 43.6 34.8 31.1 38.7 33.9 30.5 37.4 
30 42.8 38.7 47.3 37.6 33.9 41.5 27.7 24.7 30.9 
31 46.2 42.1 50.6 36.3 32.6 40.2 32.5 29.3 35.9 
32 46.1 42.1 50.5 44.7 40.4 49.1 30.5 27.0 34.2 
33 45.5 41.5 49.8 38.1 33.9 42.4 26.2 22.9 29.7 
34 44.3 40.1 48.9 30.7 27.0 34.5 26.4 23.3 29.7 
Missouri 44.5 43.8 45.2 34.0 33.4 34.6 30.2 29.7 30.8 
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From the current study’s results, as shown in tables # 1, 2, and 3, we can build FBC 
incidence profiles for the 34 Missouri senate districts. These profiles enable us to 
compare individual district’s results to Missouri and the other 33 districts’ incidence data.  
The current study’s investigators produced senatorial district interactive reporting maps 
using the Census Bureau’s Cartographic Boundary Shapefiles. Our senior statistician 
uploaded these mapping data along with the FBC incidence results obtained by analyzing 
MCR data using SEER*Stat to InstantAtlas™ to generate interactive maps [16, 17]. 
These interactive maps, in addition to the FBC incidence rates, also display FBC and 
other cancers’ mortality and survival data by county, senatorial district, and senatorial 
districts grouped to county boundaries (SDGCs). The maps visualize FBC incidence data 
and these mapping reports are in two layouts: Area profile and double map formats. 
These maps consist of joint spatial and statistical data. The following figures show the 
final layouts of the InstantAtlas™ mapping reports we constructed at the MCR-ARC to 
present Missouri FBC incidence data. In each map, District 19 is outlined in red.  
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Figure 1. Area Profile Interactive InstantAtlas™ Report Displaying Female Breast 
Cancer (FBC) Incidence Data by Senatorial District [16] 
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Figure 2. Double Map Interactive InstantAtlas™ Report Displaying Female Breast 
Cancer (FBC) Incidence Data by Senatorial District [17] 
Both mapping reports display our results in different formats (e.g., charts, tables, maps) 
[16, 17]. The area profile report shows a single map and focuses on displaying many 
indicators for every senate district and compares a district’s findings to other districts and 
to Missouri. The double map focuses on exploring the inferential statistical relationships 
between the selected indicators. [16, 17]. 
We studied the FBC incidence data results for District 19 and we compared the district’s 
results to the Missouri FBC incidence data. The following figures show the findings.  
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Figure 3. Female Breast Cancer (FBC) Incidence Rates by Age for Senate District 19 and 
Missouri (2008-2012) 
 
Figure 4. Female Breast Cancer (FBC) Incidence Rates by Race for Senate District 19 
and Missouri (2008-2012) 
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Figure 5. Female Breast Cancer (FBC) Incidence Rates by Stage and Grade Percentages 
for Senate District 19 and Missouri (2008-2012) 
District 19 includes the city of Columbia, which is the fifth largest city in Missouri 
according to the 2010 US Census and the population center of the Columbia Metropolitan 
Statistical Area (MSA). In this study, we compared District 19 to the state’s FBC 
incidence data.  
As Figures 3, 4, and 5 show, for all races and ages District 19’s incidence rates were 
higher than Missouri’s rates. Women >50 years old have a higher incidence rate than 
women <50 years old in District 19 and the state. For District 19, the incidence rate 
among women >50 years old was higher than the state’s rate for the same age category. 
The FBC incidence rates for whites and African Americans were higher within District 
19 than in Missouri as a whole. From Figure 4, we could see that the FBC incidence 
within District 19 was higher by about 40/100,000 population among African-American 
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women than among white women. The FBC incidence rate for African-American women 
in District 19 was significantly higher than the state rate. However, none of the above-
mentioned differences between District 19 and Missouri were statistically significant at 
α=.05. 
As we see from Figure 5, FBC incidence rates for late stage and grade percentages of 
District 19 were lower than Missouri’s incidence rate. The difference in stage was 
statistically significant at α=.05, with a higher late-stage FBC incidence rate in Missouri 
than in District 19. 
Figures 6, 7, and 8 show the comparison in FBC incidence rates between District 19, the 
combined districts 20 & 30, and Missouri. 
 
Figure 6. Female Breast Cancer (FBC) Incidence Rates by Age for Senate District 19, 
Combined Districts 20 & 30, and Missouri  
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Figure 7. Female Breast Cancer (FBC) Incidence Rates by Race for Senate District 19 
and Combined Districts 20 & 30 (2008-2012) 
 
Figure 8. Female Breast Cancer (FBC) Incidence Rates by Stage and Grade Percentages 
for Senate District 19 and Combined Districts 20 & 30 (2008-2012) 
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For all malignant FBC, the incidence rate for District 19 was higher than the combined 
districts 20 & 30 and Missouri. The incidence rates were comparable among each of the 
<50 and 50-64 age categories for both areas. However, for the 65+ age category, the FBC 
incidence rate for District 19 was higher than the combined districts 20 & 30’s incidence 
rate. Among white females, both areas were comparable and there was no significant 
difference. The FBC incidence rate among African Americans was higher for District 19 
than for the combined districts 20 & 30. The percent of late stages and grades at 
diagnosis was lower in District 19 than combined districts 20 & 30 and Missouri. 
However, none of the above-mentioned differences between District 19 and the combined 
districts 20 & 30 were statistically significant at α=.05.  
Discussion 
Central cancer registry databases are created from a variety of sources, including 
hospitals, pathology labs, ambulatory surgical centers, skilled nursing facilities, physician 
offices, and free-standing cancer clinics and treatment centers. The MCR data underwent 
strict quality control values and measures and the data has been assessed continually 
according to precise nationwide standards [1, 2]. 
Calculating and visualizing FBC age-standardized incidence rates by senatorial district 
could help public health officials and policy makers be informed about FBC distribution 
by age, race, grade, and stage at diagnosis within a senatorial district. This might 
effectively impact FBC policy and research, determine female at-risk sub-groups, support 
targeting FBC geographical foci, and evaluate and compare diagnostic and treatment 
strategies all over Missouri. 
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District 19 and Missouri: 
Missouri women with an income at or below 200 % of the governmental poverty level 
who are age 35 to 64 (or older if they do not receive Medicare Part B) and who do not 
have insurance to cover program services are eligible for free breast cancer screening 
through Show Me Healthy Women (SMHW), Missouri’s implementation of the National 
Breast and Cervical Cancer Early Detection Program (NBCCEDP)[18]. This could result 
in elevating FBC incidence rates in Missouri. District 19’s population is mostly urban and 
we hypothesize that most of the district’s residents who do not have insurance that covers 
breast cancer screening could access these free available services. This might explain 
why FBC incidence rates were higher in District 19 than in the majority of rural Missouri, 
where eligible women might not easily access or be educated about these free services. 
Many studies have found that screening for breast cancer seems to discover additional 
breast cancers that are possibly clinically trivial [19, 20]. Therefore, the high FBC 
incidence in District 19 might be due to over-diagnosis of early breast cancer cases 
among highly educated, mostly urban inhabitants who have easy access to screening 
services. Missouri is about 30% rural, where a higher percent of residents have less 
education and are more likely to have difficulties in healthcare accessibility and 
coverage; this could explain why the state FBC incidence rate was lower than District 
19’s rate [21]. Some studies have revealed cancer screening, diagnostic, and treatment 
disparities and inequalities between rural and urban areas. The findings were explained as 
being due to limited accessibility, poverty, and high Medicare copayment [22, 23, 24]. A 
study published in 2015 determined that cancer disparities might be reduced by 
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increasing the accessibility of under-privileged at risk and rural residents to governmental 
community facilities [25]. 
Among African-American women, the incidence rate was higher for District 19 than the 
entire state. African-American population percentages are higher in the major 
metropolitan areas than in the rural areas of the state [26]. Since a study published in 
2012 revealed racial cancer disparities among breast cancer cases [27], our study findings 
could be interpreted as rural African-Americans in Missouri as a whole have lower 
physical accessibility to screening services and education than urban District 19’s 
African-Americans.  
District 19 embraces Columbia, a minor metropolitan area. This city contains the campus 
of the University of Missouri-Columbia. The campus is inhabited by a highly-educated 
population who have health coverage and access to most healthcare services, including 
screening and treatment services. This might partially account for the higher FBC 
incidence rates for whites, African Americans, and all races in District 19 than in 
Missouri.  
Missouri high stage and grade FBC incidence rates were also higher than District 19’s 
rates. This could be explained that District 19 inhabitants have had higher education and 
higher rate healthcare coverage and accessibility to get screened for FBC and the 
opportunity of discovering treatable FBC early stages and grades. This might give them a 
higher chance to be diagnosed with FBC earlier than most women in rural Missouri. 
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District 19 and Combined Districts 20 & 30: 
The comparison findings of higher late stage and grade at diagnosis percentages in the 
combined districts 20 & 30 and Missouri than District 19 could be explained by over-
diagnosis due to using of the free screening services by District 19’s residents [25, 26]. 
So, FBC cases in the District 19 tended to be diagnosed in situ or at an early invasive 
stage and these cases are successfully treatable and do not proceed to the FBC late stages. 
Therefore, the incidence pool of late-stages incidence rates was lower in District 19 than 
in combined districts 20& 30 and Missouri. For both studied regions, FBC incidence 
rates did not have a consistent pattern of differences by age and race. 
The study findings could be very informative for cancer policy makers and public health 
professionals in both studied regions. Findings might motivate partnership between 
policy makers and other public health officials to analyze and evaluate screening and 
management cancer measures and other behavioral and socioeconomic indicators for the 
benefit of women in these areas and Missouri.  
Potential Problems and Alternative Approaches 
In high population density areas – Kansas City metropolitan area, Saint Louis 
metropolitan area and the City of Springfield – district boundaries do not follow county 
boundaries [28]. In these areas, the Census Bureau’s TIGER/Line shapefiles software 
was used to determine the district containing the latitude and longitude of the address at 
diagnosis [14].  
A problem encountered is that we did not have successfully geocoded street addresses of 
all FBC cases due to missing or inaccurate addresses. In these situations, we categorized 
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cases as residents of the most likely senate district by matching to cases that were 
successfully assigned into their senate district with the same county (if known), race (if 
known and categorized as white, African-American, or other), year of diagnosis 
(categorized into two time-periods), and the nine-digit Postal ZIP Code. When multiple 
senate districts matched, then the most common one was selected; when none matched, 
then the process was iteratively repeated by removing the least significant digit of the 
Postal ZIP Code until a senate district was imputed for every case.  
Unlike with county-level data, a detailed population file by age (in 19 groups of mostly 5-
years except with <1 year-olds and 85+), race (bridged single-race), year, and sex was not 
found at the senate district level and had to be constructed. The limitations of this 
population file are that for senate districts that do not follow county boundaries, there is a 
mismatch between the Office of Management and Budget (OMB) 1977 and 1997 race 
classifications, granular age-groupings were approximated, and there is an increasing 
inaccuracy as one moves away from 2009-2013. 
Conclusion 
Measurement of incidence rates by race, age, and by stage and grade at diagnosis may 
provide an estimation of social inequality within the state and could provide clues about 
the impact of level of coverage and accessibility to screening and health care services on 
disease prevention and early diagnosis [1]. The detailed and visually presented FBC age- 
adjusted incidence profiles by senate districts might lead researchers and policy makers to 
understand effectiveness of current breast cancer initiatives and interventions by district 
and might give clues about possible environmental and socioeconomic risk factors on 
breast cancer.  
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According to the study results and by future research based on these results, policy 
makers might embrace new effective breast cancer screening and prevention initiatives 
and interventions in Missouri, nationally and internationally. 
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Estimated Female Breast Cancer Mortality-to-Incidence Ratio 
(MIR) of the Counties and the Senatorial Districts Grouped to 
County Boundaries (SDGCs) in Missouri, 2008 – 2012 
Abstract 
Objectives: To measure mortality-to-incidence Ratio (MIR) on senatorial districts grouped to 
county boundaries (SDGCs) to explore female breast cancer (FBC) racial and age disparities in 
Missouri. 
Methods: The MIRs and their 95% confidence interval (CI) by age and race were calculated for 
20 SDGCs for the period from 2008-2012.  
Results: For the 65+ year old FBC cases, MIRs for Missouri and the 20 SDGCs were typically 
twice the MIR for the <50 and 50-64 year-old categories. The MIRs for all of Missouri and the 
compared SDGCs were higher for African-Americans than whites.  
Conclusions:  FBC MIRs can be used as a measure of cancer inequalities in Missouri. These 
measures might be informative for policy makers to assess existing policies and enforce effective 
interventions to tackle FBC disparities.  
Key Words: Disparities, female breast cancer, Mortality-to-Incidence Ratio, Race 
Introduction 
As a statistic, incidence rates estimate the actual underlying incidence of some 
conditions, but they are influenced by a number of factors. For example, incidence rates 
will be increased by increasing the intensity of breast cancer screening measures and 
interventions and these rates might be reduced by increasing prevention measures for 
cancer risk factors [1]. The incidence rates will be affected by any changes in the coding 
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and classification of any cancer. The central cancer registry database is considered to be a 
high quality controlled source to estimate the most accurate epidemiological rates 
because it is following very strict regularly updated measures and standards [2, 3]. Many 
studies have concluded the importance of estimation of multiple epidemiological 
indicators of cancers together, because presenting these epidemiological measures 
individually may mislead readers; therefore, we will conduct this project to include all the 
measurements of the same period of time [1, 3]. Many studies revealed that there are 
inequalities between cancer cases according to age, race, stage and grade at diagnosis 
variables [4, 5, 6, 7, 8, 9].  
Cancer mortality rates could inform public health leaders if the cancer is a public health 
priority at the level of state senate districts in Missouri. Using the National Vital Statistics 
System (NVSS) database of the National Center of Health Statistics (NCHS) to clarify 
cancer mortality is an excellent source of demographic, geographic and cause of death 
data [10]. Mortality rates could measure possible over-diagnosis bias in the breast cancer 
incidence and survival rates [1].  
Cancer mortality is considered as a disparity indicator, but without measuring the 
corresponding incidence it could be misleading. Elevated mortality could result from rare 
lethal cancer survival with very low incidence or from a modest survival cancer with high 
incidence rates of the same cancer [11, 12].  
Mortality-to-incidence Ratio (MIR) is a measurement that could expand our 
interpretation and understanding of the difference between the two compared 
epidemiological measures. This metric could expand the understanding of the 
demographic, environmental, and social factors which might lead to unexpected changes 
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of mortality rates based on the estimated incidence data [13]. Matching MIR for any 
cancer by race and age offers an influential method to explore the cancer magnitude and 
prognosis. The MIR will help in exploring and addressing the hidden differences in 
cancer consequences by area, age, and race [14]. MIR affords a population-based metric 
of cancer prognosis [15]. 
Numerous evidence-based studies have concluded that the use of interactive geographic 
mapping software allows users to interact in a timely way with data sets and publish high 
quality, interactive reports. The web-based mapping systems’ contribution might be 
significant because these systems could enable users to visualize the interactive mapping 
breast cancer reports easily and in a timely way, and the users can share this data with 
contributors in fields related to breast cancer. Distribution of geospatial health data will 
help public health leaders and decision makers in designing, developing, and adopting 
effective and efficient strategies and programs to improve public health outcomes 
targeting specific geographical areas [16,17,18,19].  
For instance, there are racial inequalities in cancer incidence and mortality; these 
variances are usually consequence of complicated sources. In the US, mortality rates of 
most cancers are higher among African-American than other racial/ethnic categories [20, 
12]. For all cancers, the African-American mortality rate is 25% higher than the white 
mortality rate [21]. For most cancer types, incidence rates are higher among African 
Americans than among whites and, for some cancers, African Americans are diagnosed 
with aggressive cancers at younger ages than the whites [14].  
The current study’s investigators want to estimate the female breast cancer (FBC) 
incidence using Missouri Cancer Registry (MCR) database, and assess the FBC mortality 
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of the same period using other national databases. The current study objectives are to: 1) 
measure incidence rates in Missouri from 2008 to 2012 according to female breast cancer 
(FBC) cases’ age at diagnosis, race, and the senate district grouped to county boundaries 
(SDGCs) of diagnosis,  visualizing the measured rates in InstantAtlas™ interactive 
mapping reports; 2) analyze FBC mortality rates in Missouri from 2008 to 2012 
according to age, race, and SDGC, visualizing the measured mortality rates through 
InstantAtlas™ interactive mapping reports; and 3) measure mortality-to-incidence ratio 
(MIR) of the SDGCs to explore FBC racial and age disparities in Missouri.  
Methods 
Female Breast Cancer Incidence: 
The study design is an observational epidemiological study. The investigators did 
secondary analysis on all female breast cancer cases in the MCR database from 2008 
through 2012. At the study’s initiation, 2012 was the most recent year of diagnosis with 
complete data (>95% cases reported). The starting point of 2008 was chosen arbitrarily, 
but using a 5-year period is common in research. Population data came from the mid-year 
estimates from the US Census Bureau's Population Estimates Program, which is single-
race bridged by National Center of Health Statistics (NCHS) and then released by the 
National Cancer Institute (NCI)’s Surveillance Epidemiology and End Results (SEER) 
program. NCI makes some modifications to the NCHS files but these modifications don't 
impact Missouri. The calculated incidence rates for every Missouri county was age 
standardized using US 2000 Standard Population for comparability across regions with 
differing age structures. We calculated the 95% confidence interval (CI) for these rates 
using SEER*Stat statistical package [22]. The Census Bureau’s Cartographic Boundary 
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Files (CBFs) were used to create maps showing SDGCs with a shapefile produced with 
ArcMap from the county-level CBF. A set of twenty [17] regions we termed “senate 
district grouped to county boundaries” (SDGCs) were created that minimally aggregated 
the districts to follow county boundaries. The 20 SDGCs include each of the 14 districts 
that followed county boundaries (Senate districts # 6, 10, 16, 18, 19, 21, 25, 27, 28, 29, 
31, 32, 33 & 34) along with six aggregated regions: 8 senate districts of Franklin County, 
St. Louis City, and St. Louis County; 2 senate districts of St. Charles County; 2 senate 
districts covering 6 counties south of St. Louis; 4 senate districts of Jackson County; 2 
senate districts covering 15 counties in northwest Missouri; and 2 senate districts 
covering Christian and Greene counties. Table 1 shows the SDGCs and their included 
counties.  
Incidence results were loaded along with the Cartographic Boundary Files into 
InstantAtlas™ software to produce interactive mapping reports that display our study’s 
results. The maps were published and we awill attach them to the MCR-ARC website. 
The interactive reports include maps, graphs, and tables for the 20 SDGCs [23, 24]. 
Table 1. Senate Districts Grouped to County Boundaries (SDGCs) and their Involved 
Counties. 
SDGC No. The Senate District (SD) or Counties (Cs) Involved per SDGC 
SDGC #1 SD #6 
SDGC #2 SD #10 
SDGC #3 SD #16 
SDGC #4 SD #18 
SDGC #5 SD #19 
SDGC #6 SD #21 
SDGC #7 SD #25 
SDGC #8 SD #27 
   40
SDGC #9 SD #28 
SDGC #10 SD #29 
SDGC #11 SD #31 
SDGC #12 SD #32 
SDGC #13 SD #33 
SDGC #14 SD #34 
SDGC #15 901: 01,04,05,13,14,15,24,26 (Franklin, STL City, STL County) 
SDGC #16 902: 02,23 (St. Charles) 
SDGC #17 903: 03,22 (6 counties south of STL) 
SDGC #18 907: 07,08,09,11 (Jackson) 
SDGC #19 912: 12,17 (15 Counties in the northwest) 
SDGC #20 920: 20,30 (Christian & Greene counties) 
 
Female Breast Cancer Mortality: 
The study design is an observational epidemiological study. The investigators used the 
NCHS death file to capture deaths of former Missouri residents for the period from 2008 
to 2012 [22]. The female breast cancer death data was on the county level and SDGC-
level only since the investigators could not further geocoded this data. We calculated the 
95% confidence interval (CI) for these rates as well as testing for differences from the 
remainder of the state, which are shown in the area health profile report.  
As we did for incidence rates, we used the Census Bureau’s Cartographic Boundary Files 
to create maps showing state SDGCs with a shapefile produced with ArcMap from the 
county-level CBF. The mortality results were loaded along with the CBFs into 
InstantAtlas™ software to produce interactive mapping reports that display our study’s 
results [25]. We will attach our interactive mapping reports to the MCR-ARC website. 
The interactive reports included maps, graphs, and tables for the 20 SDGCs and 115 
counties [23, 24].  
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Mortality-to-Incidence Ratio (MIR): 
 The MIRs by age and race for the FBC cases were calculated by dividing the FBC 
mortality rates by the age-adjusted FBC incidence rates for the 20 SDGCs for the period 
from 2008-2012. The researchers also calculated the 95% Confidence Intervals (95% CI) 
of the calculated MIR ratios on the log-scale using the delta method and then transformed 
the results back to the original scale. We calculated approximate CI based on a normal 
approximation to the log of the ratios. 
Results 
Our map designer at the MCR-ARC built SDGCs maps using InstantAtlas™. These maps 
were uploaded along with the results we got by analyzing incidence and mortality data 
using SEER*Stat to the InstantAtlas™ software to create the final interactive mapping 
reports [23-24]. These reports visualize incidence and mortality data results. The results 
were displayed in two formats: area profile and double map. These reports include 
combined maps and statistical data. The following screen shots show the final formats of 
the InstantAtlas™ mapping reports we built to display our results. 
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Figure 1. Area Profile Mapping Report of 65+ Female Breast Cancer (FBC) Incidence 
Rates by Senate Districts Grouped to County Boundaries (SDGCs) in Missouri 2008-
2012 [23] 
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Figure 2. Area Profile Mapping Report of Female Breast Cancer (FBC) Mortality Rates 
of Whites by Senate Districts Grouped to County Boundaries (SDGCS) in Missouri 2008-
2012 [23] 
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Figure 3. Double Map InstantAtlas™ Report of 65+ Female Breast Cancer (FBC) 
Incidence and Mortality Rates by Senate Districts Grouped to County Boundaries 
(SDGCS) in Missouri 2008-2012 [24] 
From all the above maps, we could create individual FBC mortality and incidence 
profiles for the constructed 20 SDGCs. By creating these profiles, we could compare the 
SDGCs’ results to the state and compare the SDGCs to each other. This might give 
evidence to public health professionals and cancer policy makers about FBC in their 
areas, how to evaluate cancer laws and policies, and how to consider the possible risk 
factors per area to positively impact cancer research and policy.  
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Table 2. Female Breast Cancer (FBC) Mortality-to-Incidence Ratio (MIR) and the MIR 
95% Confidence Intervals (95% CI) by Senate Districts Grouped to County Boundaries 
(SDGCS) and by Age in Missouri 2008-2012 
SDGC 
<50 50-64 65+ 
MIR 
95% CI 
LL 
95% CI 
UL MIR 
95% CI 
LL 
95% CI 
UL MIR 
95% CI 
LL 
95% CI 
UL 
Missouri 0.12 0.11 0.13 0.17 0.12 0.15 0.26 0.16 0.24 
SDGC #1 0.17 0.10 0.27 0.24 0.17 0.12 0.31 0.17 0.19 
SDGC #2 0.10 0.05 0.18 0.21 0.10 0.10 0.26 0.14 0.15 
SDGC #3 0.14 0.08 0.25 0.25 0.14 0.12 0.35 0.18 0.21 
SDGC #4 0.17 0.10 0.28 0.22 0.17 0.11 0.32 0.15 0.20 
SDGC #5       0.19   0.09 0.25 0.13 0.14 
SDGC #6 0.22 0.14 0.35 0.26 0.22 0.13 0.35 0.18 0.21 
SDGC #7 0.12 0.07 0.22 0.33 0.12 0.18 0.37 0.24 0.23 
SDGC #8 0.11 0.06 0.20 0.28 0.11 0.14 0.37 0.20 0.22 
SDGC #9 0.16 0.09 0.28 0.27 0.16 0.15 0.33 0.20 0.21 
SDGC #10       0.21   0.09 0.29 0.14 0.18 
SDGC #11 0.14 0.08 0.23 0.20 0.14 0.09 0.38 0.14 0.24 
SDGC #12 0.16 0.09 0.27 0.27 0.16 0.13 0.37 0.19 0.22 
SDGC #13       0.30   0.15 0.41 0.21 0.25 
SDGC #14 0.09 0.05 0.16 0.20 0.09 0.10 0.31 0.14 0.18 
SDGC #15 0.10 0.08 0.12 0.17 0.10 0.14 0.24 0.15 0.20 
SDGC #16 0.10 0.07 0.15 0.16 0.10 0.10 0.27 0.13 0.18 
SDGC #17 0.12 0.08 0.18 0.19 0.12 0.11 0.36 0.14 0.25 
SDGC #18 0.16 0.13 0.21 0.23 0.16 0.16 0.28 0.19 0.21 
SDGC #19 0.08 0.05 0.12 0.19 0.08 0.11 0.32 0.15 0.22 
SDGC #20 0.12 0.08 0.18 0.19 0.12 0.11 0.27 0.15 0.19 
^: Mortality and incidence statistics based on small number of deaths and new cases are 
suppressed to help protect confidentiality. In accordance with NCHS’s policies, the 
threshold of ten deceased was utilized and, as commonly used by MCR-ARC and other 
central cancer registries, the threshold of five was utilized for new cases. 
followed county boundaries (senate districts # 6, 10, 16, 18, 19, 21, 25, 27, 28, 29, 31, 32, 
33 & 34), along with the following six aggregated regions: 8 senate districts of Franklin 
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County, St. Louis City, and St. Louis County; 2 senate districts of St. Charles County; 2 
senate districts covering 6 counties south of St. Louis; 4 senate districts of Jackson 
County; 2 senate districts covering 15 counties in northwest Missouri; and 2 senate 
districts covering Christian and Greene counties. 
Table 3. Female Breast Cancer (FBC) Mortality-to-Incidence Ratio (MIR) by Senate 
Districts Grouped to County Boundaries (SDGCS) and by Race in Missouri 2008-2012 
 
 
SDGC 
White African American 
MIR 
95% 
CI LL 
95% 
CI UL MIR 
95% 
CI LL 
95% 
CI UL 
Missouri 0.18 0.17 0.19 0.25 0.23 0.27 
SDGC #1 0.19 0.16 0.24 ^ ^ ^ 
SDGC #2 0.16 0.13 0.20 ^ ^ ^ 
SDGC #3 0.21 0.17 0.25 ^ ^ ^ 
SDGC #4 0.19 0.16 0.23 ^ ^ ^ 
SDGC #5 0.14 0.11 0.18 ^ ^ ^ 
SDGC #6 0.22 0.18 0.27 ^ ^ ^ 
SDGC #7 0.22 0.18 0.27 0.35 0.19 0.65 
SDGC #8 0.20 0.17 0.25 ^ ^ ^ 
SDGC #9 0.22 0.18 0.26 ^ ^ ^ 
SDGC #10 0.17 0.14 0.21 ^ ^ ^ 
SDGC #11 0.21 0.17 0.25 ^ ^ ^ 
SDGC #12 0.23 0.19 0.28 ^ ^ ^ 
SDGC #13 0.24 0.20 0.29 ^ ^ ^ 
SDGC #14 0.17 0.13 0.20 ^ ^ ^ 
SDGC #15 0.15 0.14 0.16 0.24 0.21 0.27 
SDGC #16 0.16 0.14 0.19 ^ ^ ^ 
SDGC #17 0.20 0.18 0.24 ^ ^ ^ 
SDGC #18 0.19 0.17 0.21 0.26 0.21 0.31 
SDGC #19 0.18 0.16 0.21 ^ ^ ^ 
SDGC #20 0.17 0.15 0.20 ^ ^ ^ 
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^: Mortality and incidence statistics were based on small number of deaths and new cases 
are suppressed to help protect confidentiality. In accordance with NCHS’s policies, the 
threshold of ten deceased was utilized and, as commonly used by MCR-ARC and other 
central cancer registries, the threshold of five was utilized. 
From the MIR interactive area profile and double maps and from tables 2 and 3, we 
detected large differences in MIR by age and race for FBC in Missouri and across the 
SDGCs. These MIR differences were significant. For the 65+ FBC cases, the MIR for 
whole Missouri and the 20 SDGCs were mostly twice the MIR for the <50 and 50-64 
years old categories. In Missouri, the 65+ years old population has increased more than 
other age categories. It represents 13 % of the total population and it is expected that by 
2030 will be more than 21% because of the baby boomers [27]. Females of 65+ years old 
represented 50.9% of the total population in 2015 [28]. This group is mostly eligible for 
Medicare services.  
According to the 2010 U.S. Census, the total African-American population count was 
693,391, representing about 11.6% of the entire Missouri population [29]. African-
American population percentages are higher in the major metropolitan areas than in rural 
areas of the state [29].  In 2015, according to the U.S. Census Bureau, Missouri’s white 
population represented 83.3% and the African-American population represented 11.8% 
of the state’s total population [28]. The current study results support findings of a very 
large study done in Georgia and published in 2012 where African-Americans had higher 
MIRs than whites for each cancer type [30].  
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From the interactive map and tables 2 and 3, the current study revealed large spatial 
inequalities by age and race; these inequalities were based on rural and urban 
geographical distribution.  For FBC cases <50 years of age, the purely rural SDGC #6 
had the highest MIRs, followed by  three other rural SDGCs --  4, 9, and 12. The urban 
SDGC #18, which is a metropolitan area including Kansas City, also had a high MIR. 
FBC cases in the 50-64 age group had similar MIR findings to the FBC cases in the <50 
group. For the 65+ FBC population, the highest MIRs were distributed over most of the 
rural SDGCs but did not include SDGCs that included metropolitan areas.  
Discussion 
There are no previous efforts at MCR-ARC to assess MIR ratio variances among FBC 
cases by age and race in Missouri. By measuring these ratios, we could extend our 
understanding of the potential destiny of the diagnosed cancer cases.  
The significantly high MIRs among the 65+ years old FBC cases, in comparison to the 
other two age categories, might be interpreted as the comorbidity in 65+ year-old cases 
restricting the capability to get good prognostic choices, for example, axillary lymph 
node dissection. Comorbidities might limit management decisions, such as exposure to 
strong chemotherapy courses with or without radiotherapy. Additionally, the death from 
causes other than breast cancer of the FBC cases might be missed by the death certificate 
writers to be attributed to the breast cancer [31]. As a retrospective cohort study was 
conducted on FBC of different age categories, ≥ 70 year-old FBC cases were 
significantly less likely to get management plans consistent with their breast cancer at 
diagnosis stages and grades than younger FBC cases [31]. The same study revealed that 
diabetes, renal failure, stroke, liver disease, a previous malignant tumor, and smoking 
   49
were significant in expecting premature death for this FBC category [31]. Despite 
Medicare coverage of the 65+ year-old females across Missouri, the highest MIRs for the 
65+ year-old FBC cases were for rural Missouri. This could be attributed to the lack of 
accessibility of rural FBC cases to oncology services, lack of treatment follow-up and 
compliance, poverty, and/or to the cost of Medicare copayment [32,33]. 
A study published in 2007 found that insurance status and coverage has an important 
impact on treatment options and health consequences. Uninsured patients often have less 
intensive management and they tend to be discharged rather than referred for continuous 
care. The study revealed that uninsured patients or those with limited insurance coverage 
are more likely to be discharged from the hospital in an unhealthy condition [33]. The 
researchers explained these findings with a shortage in federal law in requiring providers 
to ensure that their patients receive all necessary care or that they be transferred to the 
most appropriate treatment setting [33].  
 Huge spatial rural-urban inequalities for the <65 year-old FBC cases were discovered by 
the current study; higher MIRs were found for rural SDGCs than the urban and 
metropolitan SDGCs. These findings could be attributed to poverty, lack of coverage, and 
inaccessibility to available diagnostic and treatment due to limited eligibility to Medicaid 
services for the poor and rural at-risk population. Despite Medicare coverage of the 65+ 
year-old females across Missouri, the highest MIRs for the 65+ year-old FBC cases were 
for the rural Missouri. This could be attributed to the lack of accessibility of the rural 
FBC cases to the right oncology services, lack of treatment follow-up and compliance, 
poverty, and/or due to the cost of Medicare copayment [32, 33]. The current study also 
revealed that the SDGCs which have better healthcare services, higher education, and 
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good socio-economic situation had lower MIRs, especially among white FBC cases [32, 
33]. Another study published in 2015 concluded that high cancer MIRs could be 
decreased by increasing the accessibility of disadvantaged minorities and rural 
inhabitants to federally-supported community centers [34].  Also, a study published in 
2006 concluded that cancer patient navigation assistance by providers could reduce MIRs 
and cancer disparities [35]. 
Conclusion  
MIRs afford a distinctive measure of cancer inequalities. MIRs could be used to estimate 
the fatality of FBC and to explore FBC age and racial disparities by area. This might help 
policy makers and intervention designers to tackle FBC effectively and efficiently in 
Missouri. From all of this, MIR ratios could construct a significant opportunity in 
outlining and resolving cancer disparities in Missouri.   
There is a plan to map the MIRs by SDGC in the near future. The mapped MIR ratios 
could be used to locate areas in need of suitable, intensive, extra consideration.  
According to the current study and previous studies’ results, there is a great need to 
conduct further evidence-based research exploring cancer comorbid diseases, social, 
behavioral, and environmental risk factors which might lead to health disparities among 
diagnosed cancer cases.  
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Estimate Female Breast Cancer Survival Data in Missouri Senatorial 
Districts and Improve Visualization of the Obtained Results Using 
Interactive Mapping Reports, 2004 – 2010 
Abstract 
Background: The Missouri Cancer Registry (MCR) collects population-based cancer 
incidence data on Missouri residents diagnosed with reportable malignant neoplasms 
(192.650-192.657 RSMo). MCR wanted to produce data that would be of interest to law-
makers and public health officials at the legislative district-level on breast cancer, the 
most common non-skin cancer among females. Our initial focus is on Missouri Senate 
District 19 (Boone and Cooper counties) and districts 20 & 30 combined (Greene and 
Christian counties). Missouri Senate District 19 contains the city of Columbia and 
Districts 20 & 30 contain the city of Springfield. These are the two largest cities in 
Missouri outside the St. Louis and Kansas City metropolitan areas. 
Objectives: Measure and interactively visualize survival data of female breast cancer 
(FBC) cases in the Missouri Cancer Registry (MCR). Secondarily, assess the geocoder 
we used to determine FBC cases’ senatorial districts. 
Methods: FBC data were linked to Missouri death records and Social Security Death 
Index (SSDI). Unlinked FBC cases were cross-matched to the National Death Index 
(NDI). FBC cases in sub-county senate districts were geocoded using TIGER/Line 
Shapefiles to identify their districts. A database was created and analyzed in SEER*Stat. 
Senatorial district maps were created using U.S. Census Bureau’s Cartographic Boundary 
Files. The results were loaded with the cartographic data into InstantAtlas™ software to 
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produce the interactive mapping reports. SAS and ArcMap were used to study the 
relationship between the types of address vs the certainty that our geocoder gave 
corresponding to addresses' Census Tracts.  
Results: All 34 senatorial districts FBC survival profiles of 5-year cause-specific survival 
percentages and 95% CI in the form of tables and interactive maps were created. The 
comparisons of District 19’s survival to Missouri and to the combined districts 20 & 30 
were conducted. The maps visualized survival data by age, race, stage, grade at diagnosis, 
and by senatorial district from 2004 to 2010. There was substantial urban–rural difference 
in the accuracy of geocoded data. 
Conclusion: Linking cancer registries’ data could improve accuracy of FBC survival, 
and could impact cancer research and policy. 
Key Words: Survival, Female Breast Cancer, Missouri, Cancer Registry. 
Introduction 
In the United States (US), it is estimated that 12 percent of women will be diagnosed with 
breast cancer at one stage of their lives [1]. Nationally, the estimated new cases of breast 
cancer were 14 percent of all new cancer cases and the estimated deaths from breast 
cancer were 7 percent of all cancer deaths in 2013 [2].  
Traditionally, incidence and mortality rates have been presented in data tables, a format 
that is easily understood by epidemiologists and statisticians but one that does not meet 
the needs of all potential users of the data. Data visualization is an alternative means of 
portraying the burden of breast cancer at various levels (e.g., county, region, state, etc.). 
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There is a critical need to build accurate fact sheets in the form of interactive and 
dynamic map reports of the breast cancer burden at the sub-state level in Missouri. 
Several studies emphasize the efficiency and importance of matching National Death 
Index (NDI) data to cancer registry data to ensure high quality and accurate population-
based cancer survival rates [3, 4, 5]. We matched the registry breast cancer data to the 
Social Security Death Index (SSDI) and the NDI. This contribution will be significant 
because, with more complete data to analyze, we can accurately estimate survival rates 
for the State of Missouri.  
Numerous evidence-based studies have concluded that the use of geographic mapping 
software allows users to interact in a timely manner with the data sets and publish high 
quality, interactive reports [6, 7, 8]. The web-based mapping systems’ contribution is 
significant because these systems will enable users to visualize cancer data easily, and 
users can share this data with contributors in fields related to the visualized cancer. 
Distribution of geospatial health data could help public health leaders and decision 
makers in designing, developing and adopting effective and efficient strategies and 
programs to improve public health outcomes targeting specific sub-populations within 
geographical areas [6,7, 8]. 
A study by Koenig, Samarasundera & Chang (2011) recognized the impact of the 
interactive mapping visualization of health data on the public health field and healthcare 
related laws and decisions. The study spotted the need for more interaction between map 
makers and the mapping reports’ beneficiaries [9]. 
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The Missouri General Assembly includes 34 senators, each representing one of 
Missouri’s 34 districts. Every senate district includes an annual average population of 
about 90,000 female residents (176,000 total residents) for the study period (2004-2010). 
Most of the districts include whole counties. In high population-density areas in the 
Kansas City metropolitan area, Saint Louis metropolitan area, and the city of Springfield, 
district limits do not follow county boundaries [10, 11].  
We aim to measure the survival rates of female breast cancer (FBC) cases in the Missouri 
Cancer Registry (MCR) database and to further analyze these survival data by stage and 
grade at diagnosis, by race, by age and by senatorial district in Missouri from 2004 to 
2010. We also aim to visualize the survival data by Missouri state senatorial district by 
creating interactive mapping reports.  
We aim also to compare geographical differences and possible inequalities in survival 
rates between the districts and the whole state and between similar districts.  For this 
paper, we will focus in detail on the results of the survival data comparison between 
District 19 and the whole state. We will also compare the survival data for District 19 
(Boone and Cooper counties), which includes the city of Columbia, to combined districts 
20 & 30 (Greene and Christian Counties), which together embrace the city of Springfield.  
To get a sense of the accuracy of the geocoded senatorial districts, we aim to conduct a 
quick and practical assessment of the geo-certainty of the geocoder the Missouri 
Department of Health and Senior Services (DHSS) used to geocode FBC cases, in order 
to determine FBC cases’ actual senatorial district for the FBC cases of senatorial districts 
which do not follow county borders. 
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Methods 
The study design was an observational longitudinal epidemiological study. The Missouri 
Cancer Registry and Research Center (MRC-ARC) updated its breast cancer data using 
Missouri DHSS’s death records and SSDI. We extracted FBC cases without a known date 
and cause of death and submitted a formatted file containing required fields to the 
National Center for Health Statistics for NDI linkage [12]. NDI staff returned a 
password-protected CD containing the search results along with our original CD.  We 
assessed the results to identify true matches. Partially matched records were reviewed 
manually using specific criteria (e.g., possible typos, use of spouse’s social security 
number, change of surname, use of compound names in a different order, use of 
nicknames, etc.). We then updated the FBC database with the linkage results.  
Only FBC cases with complete (passive) follow-up through the study cut-off of 31 
December 2011 were included in the survival analysis. Cancer registrars at reporting 
facilities record the county of residence at diagnosis before submitting the case to MCR; 
MCR staff use standard edits to validate the submission. To obtain sub-county 
information, MCR data is geocoded by DHSS to obtain the latitude and longitude (among 
other information) based on the patient’s address at diagnosis. FBC cases in counties split 
by senate districts were loaded into ESRI’s ArcMap [13] with the Census Bureau’s 
TIGER/Line Shapefiles [14] to determine their district based on their latitude and 
longitude. For this project, we used the State Senate Districts that were defined in 
redistricting following Census 2010 [15]. 
A database was created in SEER*Stat, a statistical software package for analyzing cancer 
data [16]. The 5-year cause-specific survival rates and their 95% confidence intervals 
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(Cis) were calculated for FBC cases diagnosed from 2004 through 2010. Survival was 
measured in terms of the cause-specific survival using the Surveillance, Epidemiology, 
and End Results Program (SEER) Cause-specific Death Classification Recode as the end-
point [17]. The 5-year FBC survival rates were calculated by age, race, stage and grade 
for each senate district. To protect patient confidentiality, we suppressed cells with small 
numbers, employing a commonly-used threshold of five or fewer cases [18]. 
The U.S. Census Bureau’s Cartographic Boundary Files were used to create maps 
showing Missouri counties and State senatorial districts [19]. Five-year survival statistics 
were loaded along with cancer incidence and mortality data and the Cartographic 
Boundary Files into InstantAtlas™ software to produce interactive mapping reports that 
display our study’s results [20]. The interactive reports included maps, graphs, and tables 
for the 34 Missouri senatorial districts along with 20 regions formed by aggregating 
senate districts by county boundaries, and with the 115 Missouri counties (including the 
City of St. Louis—a county-equivalent entity). The aggregated senate district regions, 
termed senate districts grouped to county boundaries (SDGSs), were formed since 
mortality data was not available at the sub-county level. 
When we geocoded the FBC cases in the sub-county districts, we encountered a problem 
in that we did not have successfully geocoded street addresses of all the breast cancer 
cases due to missing or incorrect addresses. To overcome this, we categorized them as 
residents of the most likely senate district by matching to cases that were successfully 
assigned into a senate district with the same county (if known), race (if known and 
categorized as white, African-American, and other), year of diagnosis (categorized into 
two time-periods), and the nine-digit Postal ZIP Code. If multiple senate districts match, 
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then the most common one was selected; if none matched, then the process was 
iteratively repeated by removing the least significant digit of the Postal ZIP Code until a 
senate district could be imputed for every case. 
The years of FBC diagnoses we chose for the current study were from 01/01/2004 
through 12/31/2010. This date range is the same as used by the SEER Cancer Statistics 
Review (CSR) at the time that they had complete data through 2011. Their survival cut-
off year was the one before the most recent year of diagnosis with complete data, and 
they used 7-year periods for calculating 5-year survival. We used the same case selection 
as SEER, primarily for comparison purposes with the results from other national and 
international sources.  
Early stage FBC cases consist of in situ and localized cases; late stage FBC cases include 
regional and distant cases. Low grade FBC cases involve grades I and II cases; high grade 
FBC cases include grades III and IV cases. 
District 19 and Missouri 
District 19 is near the center of the state and consists of Boone and Cooper counties. 
Boone County contains the city of Columbia, which is Missouri’s 5th largest city as of 
the 2010 Census and is the principle city of the Columbia Metropolitan Statistical Area 
(MSA). The survival within this district was compared to the entire state. For this 
comparison, we used a type I error rate (α) of 0.05 for the hypothesis tests.  
District 19 and Combined Districts 20 & 30 
In this paper, we also compared the survival in District 19 to combined senate districts 20 
& 30, which contains a similar metropolitan area, the Springfield MSA. Springfield is 
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Missouri’s 3rd largest city as of the 2010 Census and is also the principal city of the 
Springfield MSA (the 4th and 6th largest cities in Missouri are satellite cities contained in 
the Kansas City MSA). The Springfield MSA is comparable and similar in demographic 
and socioeconomic backgrounds to the Columbia MSA. Compared to Columbia’s 
demographics, Springfield is larger while Columbia is more racially diverse; their 
Hispanic compositions are similar to each other and to the state (less than 4%). Districts 
20 & 30 were grouped together so that the combined region follows county boundaries 
for analyzing mortality data. This grouping is also useful when comparing against 
District 19, since District 19 contains non-urban residents in Boone and Cooper counties 
and not just residents of the city of Columbia. We used a type I error rate (α) of 0.05 for 
the hypothesis tests in this comparison between the studied areas. 
We tested if the regions’ differences were statistically significant by determining the 
overlap of the 95% CIs of the FBC survival data.  
Measuring the Certainty of the FBC Cases’ Address at Diagnosis Geocoding Process 
To assess the accuracy of the geographical data used in this project, we compared the 
type of geocoder gave in assigning the case’s census tract. It shows how the precision is 
impacted by having cases with a large proportion of addresses that are not in the city style 
(where the city style is addresses such as "123 E Main St"). Tract certainty was used 
since "GIS Coordinate Quality" (NAACCR Item #366) is mostly blank in the MCR 
database. The study researchers used SAS software to assess the Geo-Certainty of the 
geocoded FBC cases and we visualized the results using ArcMap software [13]. 
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Results 
The senatorial districts’ 5-year cause-specific survival rates of FBC were categorized, as 
shown in tables 1-4, according to the following groupings: All malignant FBC cases, 
FBC cases < 50 years of age, FBC cases 50-64 years, FBC cases ≥ 65 tears, white race 
FBC cases, African-American race FBC cases, in situ and local FBC cases, regional and 
distant FBC cases, low grade FBC cases, and high grade FBC cases. These tables include 
the survival data for all the senatorial districts and Missouri, and the 95% confidence 
intervals of the measured survival data for all the above-mentioned categories. Using 
these tables, the reader can compare every district to each other as well as to the state’s 
rate.  
Table 1. 5-Year Cause-specific Survival Data of Female Breast Cancer across Different 
Age Groups of Females in Missouri 
Senatorial District 
(SD) 
<50 Years Old 50-64 Years Old 65+ Years Old 
Rate LL UL Rate LL UL Rate LL UL 
1 91.6 85.5 95.3 90.7 85.6 94.0 85.8 81.3 89.3 
2 92.9 87.2 96.1 89.9 84.2 93.6 79.2 71.7 84.9 
3 77.2 67.6 84.3 88.8 83.7 92.4 84.0 77.4 88.8 
4 89.5 82.2 93.9 86.9 81.7 90.7 76.3 70.9 80.8 
5 81.8 74.2 87.4 86.3 79.6 91.0 76.0 68.6 81.8 
6 85.6 77.9 90.7 86.6 80.7 90.8 81.0 75.1 85.7 
7 86.0 77.6 91.4 86.9 81.0 91.1 83.8 78.0 88.1 
8 87.2 80.4 91.7 86.5 80.3 90.8 86.7 80.2 91.2 
9 69.0 59.6 76.7 81.8 75.4 86.7 72.0 65.2 77.7 
10 90.5 82.8 94.8 86.2 79.9 90.6 83.8 77.9 88.2 
11 84.7 75.6 90.6 84.4 78.2 88.9 82.6 77.0 87.0 
12 91.1 84.1 95.1 84.7 78.6 89.2 80.8 74.6 85.6 
13 85.3 78.3 90.2 84.0 78.3 88.2 79.6 73.9 84.2 
14 80.6 73.4 86.0 87.0 81.8 90.8 83.1 76.9 87.7 
15 92.5 87.5 95.5 90.6 86.4 93.6 85.1 80.2 88.9 
16 87.5 80.0 92.3 84.3 78.1 88.9 82.6 76.9 87.1 
17 85.6 77.5 91.0 92.3 87.9 95.2 83.6 77.0 88.4 
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18 85.4 77.1 90.8 83.4 77.1 88.1 78.1 72.7 82.6 
19 87.1 79.9 91.8 87.2 81.0 91.5 83.4 75.5 89.0 
20 90.6 83.8 94.6 86.4 80.0 90.8 82.4 75.7 87.4 
21 82.7 73.1 89.1 84.9 78.9 89.3 80.0 73.6 85.1 
22 87.0 78.3 92.4 90.7 84.8 94.5 80.9 73.0 86.7 
23 90.2 83.5 94.3 91.2 86.9 94.2 88.7 83.3 92.4 
24 91.0 84.8 94.8 91.0 86.9 93.9 85.2 80.6 88.8 
25 82.9 74.3 88.9 81.7 75.7 86.4 79.1 73.2 83.8 
26 88.4 81.9 92.6 89.5 84.1 93.2 79.4 73.8 83.9 
27 86.6 77.9 92.1 84.8 78.9 89.2 79.7 73.5 84.5 
28 84.5 76.2 90.1 85.5 79.5 89.8 82.4 77.2 86.6 
29 85.0 75.2 91.2 90.7 85.6 94.0 81.1 75.3 85.6 
30 82.0 73.2 88.1 85.8 78.8 90.6 81.6 76.0 86.0 
31 87.3 78.6 92.6 87.6 81.5 91.8 78.6 72.0 83.8 
32 77.2 67.8 84.1 86.7 80.7 91.0 81.7 75.8 86.4 
33 88.2 80.2 93.1 83.8 77.4 88.6 78.6 71.9 83.8 
34 87.5 80.1 92.3 85.3 78.7 90.0 80.7 74.4 85.6 
Missouri 86.1 85 87.2 87 86.1 87.8 81.4 80.4 82.3 
 
Table 2. 5-Year Cause-specific Survival Data of Female Breast Cancer among White and 
African-American Females in Missouri 
Senatorial District 
(SD) 
White  African-American 
Rate LL UL Rate LL UL 
1 88.8 86.0 91.1 88.4 68.2 96.1 
2 87.1 83.6 89.9 88.9 43.3 98.4 
3 84.7 81.1 87.8 ^ ^ ^ 
4 85.4 81.5 88.5 76.4 70.2 81.5 
5 85.8 80.2 90.0 78.6 73.0 83.1 
6 84.6 81.1 87.4 58.3 23.0 82.1 
7 87.6 84.0 90.5 77.7 67.1 85.3 
8 86.9 83.3 89.8 77.1 53.2 89.8 
9 81.6 75.7 86.2 70.4 64.6 75.5 
10 86.1 82.5 89.0 91.8 71.1 97.9 
11 83.5 79.9 86.6 84.7 58.4 95.0 
12 84.5 80.9 87.4 ^ ^ ^ 
13 85.4 81.3 88.7 77.6 71.7 82.5 
14 89.1 84.6 92.4 79.6 74.6 83.7 
15 89.3 86.7 91.4 68.4 35.9 86.8 
   69
16 84.7 81.2 87.6 67.3 27.7 88.5 
17 87.8 84.5 90.5 75.7 41.6 91.6 
18 81.8 78.3 84.8 67.5 41.8 83.8 
19 85.1 81.1 88.4 92.1 77.5 97.4 
20 85.8 82.2 88.8 ^ ^ ^ 
21 82.7 78.8 85.9 65.6 34.3 84.7 
22 86.0 82.0 89.2 ^ ^ ^ 
23 90.0 87.1 92.3 85.2 60.6 95.0 
24 89.0 86.2 91.2 80.8 67.4 89.2 
25 81.6 77.9 84.7 67.4 48.1 80.8 
26 85.5 82.3 88.1 100 ^ ^ 
27 83.7 80.1 86.7 49.6 14.6 77.4 
28 83.9 80.5 86.7 ^ ^ ^ 
29 85.3 81.8 88.1 ^ ^ ^ 
30 83.3 79.6 86.3 56.4 7.5 88.1 
31 84.1 80.3 87.2 69.1 29.4 89.4 
32 82.2 78.4 85.4 ^ ^ ^ 
33 82.4 78.6 85.6 ^ ^ ^ 
34 84.5 80.8 87.5 72.8 41.2 89.2 
Missouri 85.4 84.8 85.9 76.8 74.7 78.7 
^: Survival statistics were based on a small number of FBC survived cases; survival data 
are suppressed to help protect confidentiality. As commonly used by MCR-ARC and 
other central cancer registries, the threshold of five (5) cases was utilized. 
Table 3. 5-Year Cause-specific Survival Data of All Malignant (Excluding In Situ but 
Including Un-staged FBC Cases), In Situ and Local, and Regional and Distant Categories 
of Female Breast Cancer in Missouri 
Senatorial District 
(SD) 
All Malignant In Situ & Local 
Regional & 
Distant 
Rate LL UL Rate LL UL Rate LL UL 
1 88.6 85.9 90.9 96.8 94.7 98.1 77.5 71.3 82.6
2 87.3 83.9 90.1 97.5 95.4 98.6 75.5 68.5 81.2
3 84.4 80.7 87.4 96.1 93.2 97.8 72.3 65.3 78.2
4 82.5 79.2 85.2 95.4 93.0 97.0 68.6 62.5 73.9
5 81.5 77.6 84.8 95.1 92.0 97.0 66.3 58.9 72.6
6 84.0 80.5 86.9 94.7 92.2 96.4 70.7 63.5 76.7
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7 85.4 81.9 88.3 95.9 93.3 97.5 74.4 67.8 79.8
8 86.7 83.2 89.5 95.5 92.8 97.2 78.0 71.0 83.5
9 75.0 70.9 78.6 92.1 88.7 94.5 60.4 53.5 66.6
10 86.2 82.7 89.0 95.7 93.1 97.3 76.4 68.9 82.2
11 83.6 80.1 86.6 94.6 91.8 96.4 74.1 67.5 79.6
12 84.5 80.9 87.4 95.3 92.6 97.0 71.7 64.5 77.8
13 82.6 79.3 85.4 94.6 92.1 96.3 69.8 63.7 75.1
14 83.9 80.6 86.7 96.2 93.7 97.7 71.7 65.8 76.8
15 89.0 86.4 91.1 96.3 94.3 97.6 78.3 72.6 82.9
16 84.3 80.8 87.2 95.2 92.5 96.9 74.5 67.7 80.2
17 87.4 84.1 90.1 97.7 95.5 98.9 73.4 66.1 79.3
18 81.3 77.8 84.3 94.9 92.2 96.7 67.7 61.1 73.4
19 86.0 82.3 89.0 95.7 92.6 97.5 73.0 65.5 79.0
20 85.9 82.3 88.8 95.6 93.0 97.3 77.1 70.0 82.7
21 82.3 78.5 85.5 95.8 92.8 97.6 68.7 61.7 74.7
22 86.4 82.5 89.5 95.4 92.4 97.2 76.2 68.1 82.6
23 90.0 87.2 92.2 97.8 95.6 98.9 80.4 74.5 85.1
24 88.5 85.9 90.7 96.5 94.5 97.8 77.2 71.3 81.9
25 80.8 77.2 83.9 94.7 92.0 96.6 66.4 59.4 72.5
26 85.4 82.3 88.1 94.9 92.4 96.6 74.1 67.6 79.5
27 83.0 79.4 86.0 94.6 91.7 96.5 69.6 62.3 75.7
28 84.0 80.6 86.8 95.7 93.1 97.4 73.3 67 78.6
29 85.2 81.8 88.0 96.7 94.4 98.1 71.5 63.8 77.9
30 83.0 79.4 86.1 94.2 91.2 96.2 69.5 62.1 75.7
31 83.8 80.1 86.9 94.4 91.4 96.4 75.0 67.6 80.9
32 82.4 78.7 85.6 94.7 91.8 96.5 67.2 59.5 73.8
33 82.6 78.7 85.7 93.0 89.6 95.3 69.7 62.0 76.2
34 84.1 80.5 87.1 96.0 93.4 97.6 70.8 63.3 76.9
Missouri 84.5 84.0 85.0 95.5 95.1 95.8 72.3 71.2 73.4
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Table 4. 5-Year Cause-specific Survival Data of Low- and High-Grade Categories of 
Female Breast Cancer in Missouri  
Senatorial District 
(SD) 
Low Grade High Grade  
Rate LL UL Rate LL UL 
1 93.8 90.6 95.9 84.0 77.9 88.6
2 94.2 90.8 96.4 81.5 74.0 87.0
3 93.2 89.1 95.8 75.9 68.5 81.8
4 90.5 86.8 93.2 75.8 69.5 80.9
5 87.6 82.3 91.3 76.8 70.3 82.1
6 90.8 86.9 93.6 77.3 70.0 83.1
7 93.1 89.4 95.5 76.9 69.3 82.8
8 91.9 87.6 94.8 77.6 70.2 83.5
9 83.0 77.8 87.1 68.8 61.5 75.0
10 91.1 86.8 94.0 79.7 71.7 85.7
11 90.3 86.6 93.0 75.7 68.0 81.8
12 91.2 87.5 93.9 76.0 67.5 82.6
13 89.9 86.1 92.7 71.3 64.8 76.8
14 91.9 88.1 94.5 77.7 71.7 82.5
15 95.2 92.5 96.9 81.7 75.7 86.3
16 90.0 85.8 93.0 80.5 73.9 85.5
17 91.5 87.9 94.1 82.4 74.4 88.2
18 90.2 86.3 93.0 75.7 68.5 81.5
19 91.9 87.6 94.8 73.9 65.8 80.3
20 95.3 92.0 97.3 77.7 70.9 83.1
21 89.6 85.4 92.7 76.8 69.1 82.8
22 94.4 89.8 96.9 77.6 69.7 83.7
23 92.3 88.9 94.8 86.3 80.2 90.7
24 92.8 89.8 95.0 85.3 79.8 89.4
25 89.1 84.4 92.4 73.7 66.9 79.4
26 91.9 88.4 94.3 77.8 71.0 83.2
27 90.8 86.7 93.7 76.8 69.7 82.4
28 91.8 88.0 94.4 81.9 76.0 86.5
29 91.5 87.4 94.3 81.2 74.7 86.3
30 91.4 87.4 94.1 77.0 70.1 82.6
31 90.9 86.6 93.9 80.9 73.6 86.3
32 92.8 88.6 95.5 72.1 65.1 78.0
33 92.0 87.8 94.8 75.4 68.4 81.1
34 89.4 85.4 92.3 78.7 69.2 85.5
Missouri 91.4 90.8 92 77.8 76.7 78.8
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The reports display survival data results in two layouts: an “Area Profile” focused on 
displaying many indicators for one or a small number of selected districts along with 
results from statistical hypothesis testing; and a “Double Map” which displays two 
indicators simultaneously along with a district- (SDGC- or county-) level scatter-plot. 
These reports include combined maps and statistical data. The following screenshots 
show the final formats of the interactive mapping reports we built at the MCR-ARC to 
display Missouri FBC survival data along with other incidence and mortality data.  
 
Figure 1. Area Profile Interactive Report Displaying FBC 5-Year Cause-specific Survival 
Data by Senatorial District [21] 
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Figure 2. Double Map Interactive Report Displaying FBC 5-Year Cause-specific Survival 
Data by Senatorial District [22] 
District 19 and Missouri 
We explored the survival data for District 19 and we compared the district’s results to the 
state’s results. The following figures show the findings. 
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Figure 3. FBC Survival Percentages by Age for Senate District 19 and Missouri (2004-
2010) 
 
Figure 4. FBC Survival Percentages by Race for Senate District 19 and Missouri (2004-
2010) 
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Figure 5. FBC Survival Data by Stage and Grade for Senate District 19 and Missouri 
(2004-2010). [Note: “Early stage” consists of in situ and localized; “late stage” is 
regional and distant. “Low grade” consists of grades I-II; “high grade” is grades III-IV.] 
For all races combined and all ages combined, the district’s cause-specific survival rates 
were higher than Missouri’s rates. For the FBC <50 year old group, the district survival 
rate is higher than the state’s rate. For the FBC ≥50 year old group, Missouri survival 
rates were higher than the district’s rates. Among whites, the district’s rate was lower 
than the Missouri rate. Among African Americans, the Missouri survival rate was lower 
than the district’s survival rate. For District 19, the survival rate among African-
American women was higher than the survival rate among white women. For all stages, 
the district’s survival rate was higher than the Missouri survival rate. Overall, survival 
outcomes were higher for the district than for Missouri.  
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However, none of the above-mentioned differences between District 19 and Missouri 
were statistically significant at α=.05  
District 19 and Combined Districts 20 & 30 
 
Figure 6. FBC Survival Percentages by Age for Senate District 19 and the Combined 
Districts 20 & 30 (2004-2010) 
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Figure 7. FBC Survival Data by Age for Senate District 19 and the Combined Districts 20 
& 30 (2004-2010) 
 
Figure 8. FBC Survival Percentages by Stage and Grade Percentages for Senate District 
19 and Combined Districts 20 & 30 (2004-2010) 
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For all malignant FBC cases combined, District 19 had better survival rates than 
combined districts 20 & 30. For the <50 and 50-64 age groups, District 19 and combined 
districts 20 & 30 were comparable. For the 65+ age group, District 19 had survival rates 
lower than combined districts 20 & 30. African-Americans had higher survival rate than 
whites in District 19 but lower in combined districts 20 & 30. The survival rates of late 
stage FBC were similar between the two studied regions. Among high grade FBC cases, 
District 19 had a lower survival rate than combined districts 20 & 30.  
After analyzing all the above-mentioned differences, we did not find any statistically 
significant differences between the two studied regions.  
Measuring the Certainty of the FBC Cases’ Address at Diagnosis Geocoding Process 
As we discussed in the methodology, we assessed the accuracy of the geocoding process, 
which was conducted by DHSS using commercial software and measured the geo-
certainty of the FBC geocoded cases. The generated maps (not shown) displayed the geo-
certainty of the addresses at diagnosis of all FBC cases which were diagnosed 2004-2012 
along with the types of addresses which were sent to the geocoder. 
Discussion 
The Missouri Cancer Registry (MCR) currently is an incidence-only registry since it 
lacks complete survival information. MCR needs to become a survival registry to be able 
to measure the impact of Missouri public health programs on survival. The measured 
survival rates will transform our registry from being an incidence registry to becoming a 
survival registry.  
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Survival data mirrors FBC prediction in a specific period [23]. We used the MCR records 
because it is a population-based registry with data that originates from diverse sources 
including hospitals, ambulatory surgical centers, freestanding cancer treatment centers, 
pathology labs, long-term care facilities, and physician offices. It also obtains cases 
obtained through case-sharing agreements with 19 states. MCR data go through very firm 
quality control standards and the data are evaluated repeatedly following specific national 
measures [24]. Several studies have revealed the significance of linking NDI data to 
central cancer registries data to confirm high quality and more accurate population-based 
cancer survival data [3, 4, 5]. 
From all the current study’s results, as shown in tables 1, 2, 3, & 4, we will be able to 
create FBC survival profiles for the 34 Missouri senate districts. By creating these 
profiles, we will be able to compare each district’s results to the state and to other 
districts’ results and give more detailed information to public health practitioners and 
decision makers about FBC in their district. 
District 19 and Missouri 
The results displayed in the figures 3, 4, & 5 could be very informative for decision 
makers and public health practitioners. These findings might be used to explore 
effectiveness of current breast cancer initiatives and interventions at the district and the 
State level, to study impact of coverage and accessibility to screening and health care 
services, and to explore issues related to social inequality. 
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District 19 and Combined Districts 20 & 30 
In figures 6, 7, & 8, we compared survival data for District 19 and the combined districts 
20 & 30. We know that the compared districts are not exactly similar in population 
composition or in rural urban ratio, but by doing this comparison we compared FBC 
survival data for areas that contain two major cities in Missouri. The two largest public 
universities in the state are in these two cities and each city contains multiple medical 
facilities and specialty physicians. We assume that a large percentage of these cities’ 
inhabitants have had easy physical access to breast cancer screening services in 
community health centers as well as advanced health facilities. 
For both studied regions, survival data did not have a consistent pattern of differences by 
age or race. These findings could be very informative for decision makers and public 
health practitioners in both geographic areas and might enhance collaboration between 
decision makers to review and assess screening and treatment services to attain the best 
outcomes. 
Mapping Reports 
In MCR-ARC, we need to present our data in formats that meet the needs of a wide range 
of potential data users. That is why we chose to combine our survival data with 
geographical data to produce interactive mapping reports at the Missouri senate district 
level. InstantAtlas™ is an interactive, internet-based mapping tool licensed to the MCR-
ARC which allows users to visually display data gathered from the registry database. Use 
of interactive data visualization and mapping software allows users to interact with the 
data sets. We built two interactive mapping reports including our Senate District level 
FBC survival data [21, 22]. The two maps were Area Profile Map and Double Map; we 
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have not publicized these maps yet on the MCR’s website. The area profile report shows 
a single map and focuses on displaying many indicators for a selected senate district and 
compares the district’s findings to the others and to Missouri. The double map focuses on 
exploring the relationships between the selected indicators. Double map displays two 
indicators simultaneously along with a scatter-plot or a table. 
Measuring the Certainty of the FBC Cases’ Address at Diagnosis Geocoding Process 
To meet the goals of controlling and preventing cancer in the community, public health 
and cancer scientists should assess the accuracy of existing geocoding tools. With this 
technique, the most accurate geocoded data will be available to interested researchers, 
motivate geographic epidemiology research, and enhance further effective and targeted 
cancer control [25]. 
We measured the geo-certainty of the FBC geocoded cases from 2004-2010. This 
analysis demonstrates how the accuracy is influenced by having cases with a large 
proportion of addresses that are not in the city style (where the city style are addresses 
such as "123 E Main St"). The study investigators found that the address at diagnosis’s 
geo-certainty and accuracy were much higher for urban and metropolitan Missouri areas 
than for rural areas of Missouri. The geo-certainty for FBC cases who lived in urban 
areas at time of diagnosis was more accurate because most of these cases have city-style 
addresses. This helped the geocoder to interpolate the longitude and latitude of the 
addresses accurately. Rural area FBC geocoding tended to be less accurate because many 
cases had non-city-style addresses. These rural cases were often geocoded based only on 
their Postal ZIP Code™ with five or fewer digits, giving poor spatial resolution. There 
were substantial urban–rural differences in the accuracy of geocoded data.  
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Accurate latitude and longitude was only needed for FBC cases in three urban areas (St. 
Louis Metro area, Kansas City Metro area, and Greene County) because only in these 
areas do senate districts not follow county borders. In the current study, we used the 
geocoder to determine actual senate districts of FBC cases in these urban areas. While 
rural FBC cases might tend to have poor latitude/longitude accuracy, for the current 
study, the uncertainty was acceptable since many of the rural areas have counties 
aggregated together; we did not need to geocode FBC cases from these regions since 
county at diagnosis is sufficient. The geo-certainty assessment was not an issue for 
SDGCs because all 20 SDGCs follow county boundaries. 
Study Challenges and Limitations 
During the matching processes, some cases did not have a social security number, which 
is the best available unique identifier. Also, some identifiers, such as date of birth and last 
and/or first name, showed differences when the NDI database and the registry database 
were compared. This may be due to data entry typos or changed last name. Such cases 
were manually reviewed. Manual review of all partial matches was done by more than 
one MCR-ARC staff member to reduce possible mistakes. 
Survival rates were measured using cause-specific survival rather than relative survival 
(another common net measure of survival) to avoid the need of having detailed 
population lifetables. Potential disadvantages of using cause-specific survival are that, 
unlike relative survival, it relies on additionally having the cause-of-death rather than just 
the fact and date of death and, moreover, it relies on accurate coding of the cause-of-
death [17]. To decrease the number of known decedents with unknown cause-of-death in 
the MCR database, these cases were included in the NDI linkage to try to obtain their 
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cause-of-death. To lessen the impact of miscoded cause-of-death (e.g., a breast cancer 
death being misattributed to the location of a metastatic site). The rates used here had 
defined "breast cancer death" according to the SEER Cause-specific Death Classification 
Recode variable [17].  
Future Directions 
In the future, by combining mortality and incidence data in the survival profiles, we will 
be able to inform every district’s decision makers about the full picture of FBC burden by 
district and we could help them assess FBC interventions and policies on geographical 
bases. Due to small sample sizes, we do not have county-level results from the 
Behavioral Risk Factor Surveillance System (BRFSS), which is a state-based health 
survey that annually gathers data on health events, behaviors, preventive practices, and 
access to health care. A similar survey, the County-level Study, was done on the county 
level in Missouri [26]. In the future, we could combine these results to the survival data 
and create InstantAtlas™ mapping reports including survival and other measured 
contextual indicators. This kind of mapping report could be used to explore the 
relationship between FBC and other measured contextual indicators all over Missouri. 
In this paper, we measured 5-year cause-specific survival rates of FBC for the 34 senate 
districts in Missouri. In the future, we will consider the feasibility of measuring the same 
rates for all 163 Missouri legislative districts [27, 28]. 
Conclusions 
Net measures of survival factor out other causes of death and are useful from a policy-
based perspective. These measures enable comparisons of cancer survival across 
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geographical regions and between groups of patients without differences in background 
rates of other causes impacting the results. 
Cancer registry data is very rich and can be used in exploration of many scientific 
theories and models. Registry data could be a valuable source to get survival rates of 
breast cancer cases by race, age, and stage at diagnosis. Using cancer registry data 
supplemented by SSDI and NDI information will be beneficial and could improve 
accuracy of breast cancer survival by age, stage or race as well as by geographic area 
(counties and senatorial districts). 
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Geographic Information Systems: Usability, Perception, and 
Preferences of Public Health Professionals 
Abstract 
Background: Analyzing and visualizing health-related databases using Geographic 
Information Systems (GISs) becomes essential in controlling many public health 
problems.  
Objectives: To explore the perception and preferences of public health professionals 
(PHPs) about the usability of GISs in public health field 
Methods: A scoping review. The investigators searched Medline Ovid and PubMed 
databases for The following key- terms 1) Geographic Information System (GIS) OR GIS 
OR mapping software, AND 2) public health OR public health practitioners, AND 3) 
usability OR functionality OR utility OR perception OR, preferences. The search resulted 
in two articles. The PubMed was searched with the same strategy and did not produce 
any results. The investigators tried to search the key- and MESH-terms differently using 
PubMed database and found a usability article which is strongly related to the current 
study aim. The investigators searched the related articles of that study and got 55 strongly 
related articles. Finally, nine articles met the review’s inclusion criteria. 
Results: Iterative evaluations, extensive training, and involvements of GIS end users are 
productive in GIS usability. More methodologies are needed to support the validity of 
GIS usability studies. The exchange of GIS technology impacts public health policy and 
research positively.  
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Discussion: PHPs are aware of the use of GISs in public health field, and exchange of the 
visualized health-related in determining the inequalities and inaccessibility issues.  
Conclusion: GISs are essential to control public health problems if the related health 
datasets analyzed carefully and if the mapping reports extensively evaluated and 
interpreted.   
Keywords:  Geographic Information systems, GIS, Public Health, Usability  
Introduction 
Public health work requires collaboration and effective communication between public 
health team members [1]. Therefore, the Geographic Information System (GIS) tools 
should be designed to meet the needs and perspectives of the team members. The 
problem today is not in creating new GISs, but in effective and efficient use of the 
existing ones [2, 3].  
Analyzing and visualizing health-related databases, using sophisticated statistical 
software, is essential in helping control many public health problems in any community. 
This data should be handled carefully and analyzed adequately to get reliable results and 
not mislead the target audiences [4].  
Most of the potential users of the health related spatial data find difficulties in 
interpreting statistical and mapping information of most health-related spatial reports 
[5,6,7]. The major issues are the lack of experience and training to use this technology, 
lack of acceptance to use GIS tools, and the complicated design of the most existing GIS 
technology [8]. Providing the potential users of GISs software with clear explanations on 
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the statistical methodology and results, analogies of the combined diagrams and maps 
will enhance the users’ understanding and motivate them to use this technology [9]. 
Mapped public health data can create knowledge, produce evidence, and generate 
policies [10]. Every mapping report should carry a specific purpose and a clear message 
to the audience [11].  Targeting the Public Health Professionals (PHPs) and policy 
makers, the mapping reports should include citations of the used databases’ sources and 
the methodology of the results. I order to make it user friendly, the usability of the GIS 
tools and reports should be iteratively tested using pilots of the potential users before and 
after tools’ release [4].  
Current literature proves the collaboration between the professionals of the same public 
health interest through linking health information from different sources through 
designing portals and applications [12]. This will help guide PHPs and policy makers to 
develop cost-effective public health interventions [12]. Over the last 20 years, spatial 
health data are transformed from being static to being interactive and dynamic [13].  
GIS tools could help in communication between experts in different fields, and the GIS 
developers and users should consider technical, social, and cultural issues during 
development, evaluations, and the updating of the GISs tools to enhance the experts’ 
connection [14]. The investigators of the current scoping review could not find previous 
literature reviews adopting the same aim, including all of this review’s inclusion criteria 
(see methods section), covering exactly the time limits of this review, and/or using the 
same searching strategies and the similar keyword terms used in the current review. 
   94
The current scoping review’s aim is to explore the perceptions and preferences of public 
health practitioners and policy makers about the use of GISs in public health practice, and 
to search the literature about the usability and utility of GISs in public health fields.   
Methods 
Study Design and strategy 
The study design was a scoping review research. The investigators searched for eligible 
journal articles in the following databases:  Medline Ovid and PubMed databases. The 
following key- and MESH-terms were searched using Medline Ovid: 1) Geographic 
Information System (GIS) OR GIS OR mapping software, AND 2) public health OR 
public health practitioners, AND 3) usability OR functionality OR utility OR perception 
OR, preferences. The search resulted in two articles. The PubMed was searched with the 
same strategy and did not produce any results. The investigators tried to search the key- 
and MESH-terms differently using PubMed database and found a usability article which 
is strongly related to the current study aim. The investigators searched the related articles 
of that study and got 55 strongly related articles. Finally, nine articles met the inclusion 
criteria (Figure 1) 
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Figure 1: Search Strategy Flow Chart 
Inclusion Criteria  
Eligible articles for this review were written in English, published in the years from 2000 
to 2016, and included usability interviews or usability testing of public health 
professionals (PHPs) and/or decision- or policy-makers. In the usability testing literature, 
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the studies test the usability of: GISs, mapping atlases, mapping applications, or spatial or 
spatial-temporal websites and/or portals. These mentioned tools should display spatial or 
spatial-temporal public health data. In the usability studies, the inclusion criteria for the 
users were public health practitioners or professionals, epidemiologists, public health 
program directors, spatial reports developers and analyzers, and public health policy 
makers. 
According to the study design and the methodology, we divided our selected articles 
into: 
1. Articles based on usability testing of GIS tools, applications, and or websites 
display spatial-temporal data: Four articles met the study inclusion criteria.  
2. Articles based on interviewing PHPs and policy-makers to find out their GISs’ 
perspectives and preferences in public health field: We have five eligible articles 
in this category.  
Results 
The results of the nine eligible articles were not comparable because: the participants 
were different (demographics, experience, work type, and degree of education), they 
were testing different GIS software and they were interviewing participants using 
different research measures. See Table 1 and Table 2. 
Usability Testing Studies:  
Usability Testing Studies Based on Testing GIS Tools by Participants: 
There are four articles in this category. The important information about the studies was 
extracted and presented in Table1.  
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Table 1. Usability Testing Studies Based on Testing GIS Tools by Participants 
 
The first study was conducted by a geography scholar. The study’s objective was to 
explore how the epidemiologists take advantage of the geo-visualized technology, and 
how they expect this information to help them in practice. The study design was usability 
testing of the Exploratory Spatial-Temporal Analysis Toolkit (ESTAT) which visualizes 
multivariate health data to support cancer epidemiology. The study was user-centered and 
the researchers conducted iterative evaluation processes to refine ESTAT.  
Author
Year and 
Country Aim Study Design Methodology Main Findings Recommendations
Rhobinso
n  et al
2007/US
A
To assess how 
epidemiologists 
perceive and use GIS 
technology in their daily 
practice, and testing the 
usability of a GIS tool 
used to present and 
visualize multivariate 
health data
Mixed 
Methodologies. 
User centered 
design method. 
Iterative evaluations 
In 2003:  A graduate students sample 
conducted card sorting and verbal protocol 
analysis.  2004 (a): Cancer seasoned 
epidemiologists (actual tool’s end users) 
conducted protocol analysis and focus group 
activities. 2004 (b): Case study to investigate 
the studied tool in collaboration with 
epidemiologist for several months. 2004 (c): 
Five expert epidemiologists participated in 
Individual user task analysis to test usability 
of the refined system
2003: Shifting to the actual tool’s end-users will 
be better to test the tested tool.  2004(a): The 
tool was tested by the actual end users. 2004(b): 
the collaborated epidemiologist brobed many 
usability issues of the tool, was a successful 
case-study.  2004 (c): based on the previous 
stages’ results, the users focused more on the 
tasks rather than the interactions. It was a 
successful iterative evaluation steps to refine 
the tested tool
Functionality and utility of any tested tool are 
much important as the user-interaction of that 
tool. Iterative and mixed methodology 
evaluations should be conducted to assess any 
GIS tool. The actual users must be involved in 
the usability study of GIS tools.  Usability 
should be evaluated extensively before 
releasing the tool to the actual users. Case 
study evaluation is very fruitful to assess any 
tested tool. 
Bhowmick2008/USA
To test usability and 
utility of Pennsylvania 
Cancer Atlas (PA-AT) 
using Delphi application 
to further update the 
software
Mixed 
Methodologies. 
Iterative user-
centered design. 
Usability testing , 
focus groups and 
surveys.
Stage 1: (2 groups) GIS science graduate 
students (n=7) and cartography and 
information visualization experts (n=4). Stage 
2: (2 groups) epidemiologists (n=7) and 
spatial analysts and state public health 
professionals (n=7). Stage 1 &2 had 4 rounds
Best reports included tables, maps, and graphs 
for cancer control professionals. Difference in 
experience is obvious in dealing with the 
reports. The authors concluded some 
advantages and disadvantages of web-based 
questionnaire and communication with study 
participants. The results of the assessment were 
positive from both stages as following: 
improving interaction function, enhancing 
methods of temporal analysis, addressing data 
issues, providing additional displays and help 
utility of the atlas. This research demonstrated 
the potential of distributed web-based tools to 
support group input to health geographic tool 
design.
To continue improve the design of the PA-CA, 
the investigators should continue considering 
the end-users and make further evaluations. It 
is important to get feedback and suggessions 
from end users of different experience
Cinnamon 
et al
2009/ 
Canada
To test usability of 
different kinds of the 
geo-visualization maps
Mixed 
Methodologies. 
Usabiliy testing of 
static, interactive, 
and animated maps 
of injuries devloped 
after needs 
asesment and map 
designing 
The injury and socio-demographic data were 
mapped and uploaded to a developed 
website. Eight Participants from different 
public health backgrounds are participated in 
the usability testing sessions. On site, usability 
testing sessions were conducted with just an 
assistant to observe and write the 
participants’ comments and interactions. The 
sessions followed by a questionnaire to be 
filled out by participants. The usability study 
was ended by short discussion about the 
sessions and the tested maps
Different maps are useful for different purposes 
and for satisfying the varying skills of the users. 
Static: versatile and easy to use. Animated: 
more effective. Interactive maps are the most 
preferred maps to compare patterns of injury 
and sociodemographic risk factors. Most of 
users agreed on time, cost, experience in map 
analysis, and availability of right data as 
limitations to use maps. All participants are 
strongly agreed on maps as useful tools in 
prevent and control injury prevention
Any geographic visualization techniques that 
could be applied to public health should be 
tested. To validate any usability testing study 
results, different profiles of end-users should 
be tested using control groups.
Koenig 2011/UK
To conduct a pilot study 
exploring preferences 
and perspectives of the 
public health 
practitioners regarding 
the internet-based and 
interactive geo-
visualization technology 
and tools. 
Usability testing 
using a convenience 
sample of PHPs 
using structured 
human-computer 
interaction face-to-
face interviews. 
Seven academia based PHPs were 
interviewed. The participants were 
categorized as novice, intermediate, Experts. 
Five sections questionnaire: user experience, 
diverging color schemes, classification 
schemes, graphical representation, interactive 
mapping. A structured interviews to assess 
the participants’ understanding of GIS 
morbidity data were conducted. The 
questionnaire also tested the participants’ 
visualization preferences of the GIS 
technology. 
Novice participants faced difficulties in 
interpreting the sophisticated mapping and 
statistical information of the tested interactive 
GIS material. The novice participants also 
struggled with making links between the 
cartographic and the associated statistical 
information. 
Novice PHPs will benefit from an extensive 
interpretation of the interactive mapping 
methodology, sources, and results. The 
interpretation should not be just through 
sophisticated technology, but also through 
increasing the interaction between PHPs and 
mapmakers. This will enhance PHPs and 
public health policy makers to adopt GIS 
technology in public health problems’ 
prevention and control.  
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The study design was multi-staged. In the first stage: This stage was conducted on 
graduate students using card sorting and verbal protocol analysis types of evaluation. 
After a year, the study investigators shifted to the actual end-users after they had 
problems with some tool’s interface. In the second stage: The researchers carried verbal 
protocol analysis on 12 epidemiologists followed by focus group activities to discuss the 
testing usability sessions. Verbal protocol is defined as: “A psychological research 
method that elicits verbal reports from research participants” [15]. In the third stage: A 
case study by collaboration with an academic epidemiologist to analyze ESTAT. His 
analysis was a positive addition to the tool’s design. In the fourth stage: Five experts in 
data analysis tested the refined tool using verbal protocol analysis followed by focus 
groups. Scatter plot was the first analytical measure the epidemiologists used followed by 
bivariate map tools. The complicated and multivariate tools of the ESTAT were not used 
commonly with the users. The most interesting finding of this stage was that the users did 
not face a lot of interaction problems, and this indicated improvement in development 
and refinement of the tool [16].  
The second study was conducted by scholars from four different specialties and expertise: 
public health, geography, clinical medicine, and cancer research institute. The study 
objective was to test the usability and utility of the Pennsylvania Cancer Atlas (PA-CA) 
to refine the software. The study design was multi-staged user-centered evaluations of 
PA-AT usability using web-based application (Delphi application). In the first stage: The 
investigators tested the PA-CA using two groups of users. The first group included seven 
GIS science graduate students, and the second group formed from four cartography and 
information visualization experts. Second stage: Included two groups, seven 
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epidemiologists in the first group, and seven spatial analysts and Pennsylvania state 
public health professionals in the second group. Every stage of evaluation had four 
rounds of testing sessions. The professional participants pointed out that the best spatial 
reports included tables, maps, and charts. The responses and the using of the tested 
spatial reports were varied by the difference in expertise. Most of the participants stressed 
on the importance of integrating tutorials and help information for the PA-CA end-users. 
The results of the evaluation processes were totally positive. The testers came up with 
important recommendations on the PA-CA software: improving user-software interface 
and motivating new methods of temporal analysis. The other main finding of the study 
was the ability to distribute web-based tools to access different kinds of experts and 
recruit them to test the design of GIS tools [17].  
The third study was conducted by researchers of different scientific backgrounds: 
geography, medical school, and public health specialties. The study design was multi-
staged. First stage: There was a user needs assessment through meetings with public 
health stakeholders who described the need for injury related GIS tools and reports. 
Second and third stages: Which is named as the map development stage. Three map types 
were created by the researchers. The maps were: static, animated, and interactive maps. 
The created maps displayed the injury data and its socio-demographic determinants. 
These maps were uploaded to a developed website. Fourth stage: The uploaded maps 
were tested using a sample of public health officials and injury prevention stakeholders. 
The usability testing sessions were on-site with an observer to write down the users’ 
comments and their map-interface. The sessions were followed by a self-filled out 
questionnaire and short discussion per participant.  All the participants revealed that all 
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map types are useful for different purposes. Most of them pointed out that the animated 
maps are more effective than the static maps, and the best maps to effectively compare 
the injury data to its socio-economic determinants were the interactive maps. Most of the 
users agreed on the effect of the resources in terms of time, money, expertise on the map 
development industry, and the availability of right and appropriate data to build 
successful maps [18]. 
The fourth study was carried out by three scholars from different specialties and 
educational institutions: Public health science, environmental and engineering science, 
and geography science. The study aims were to conduct a pilot study on a sample of 
PHPs to explore their comprehensive and visualization preferences of the interactive 
online-based mapping reports, and to evaluate the effectiveness of the interactive 
mapping reports’ formats and measure the actual end-users’ interactions with the tested 
GIS tools.  
The study design was built firstly on a five sections interviewing questionnaire. The test 
was on-site, face-to-face, and a GIS-based interview. The interviews were accompanied 
with direct observation and think-aloud protocol. The participants were asked to examine 
the tested visualization material, answer the questions, and write down their preferences, 
perceptions, and expectations on the tested material. The recruited seven academia PHPs 
were assigned according to their expertise of using disease visualization maps, based on 
their answers on a specific question to: Novice, intermediate, and expert categories. The 
interviews included five sections in a well-structured questionnaire: -user experience, 
diverging color schemes, data classification schemes, graphical representation of 
morbidity data, and interactive mapping usability tasks. The novice participants had 
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problems in exploration of the data classifications, in understanding the supplementary 
sophisticated statistical graphics, and in linking the interactive tables with the maps of the 
tested reports. There were differences in the perception of the interactive mapping reports 
among the participants according to their previous geographic experience [19].   
Usability Studies Based on Just Interviewing the Participants: 
There are five articles under this category. The articles’ methodologies were based on 
interviewing PHPs, cartographic scientists, map developers, and/ or public health policy 
makers. See Table (2). 
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Table 2.  Usability Studies Based on Interviewing the Participants 
 
Author
Year and 
Country Aim Study Design Methodology significant findings Recommendations
Ghetain et 
al 2008/USA
To evaluate usability and 
utility of GIS technology 
this is used in cancer 
research and policy
A phone interview 
based usability 
Study
the participants recruited 
through email invitations. 49 of 
50 States' Cancer Control 
directors were interviewed 
about the use of GIS in cancer 
research and policy 
According to the participants responses: (1) Advantages 
of using GIS in cancer policy: identify services 
inadequacy, explore accessibility, knowing population at 
risk, and classifying cancer staging. (2) Research 
advantages: monitoring and surveillance, important 
statistical and cartographic resources, generate research 
questions and hypotheses (3) Relation between mapped 
Behavioral risks data and perceived advantages: : There 
were significant relationship between using behavioral 
risks mapped data and only the determination of at risk 
population policy. (4) Cancer incidence, mortality, and 
staging there was no significant relation of this mapped 
data to cancer policy, but it was significantly related to 
producing etiology hypotheses research advantage. (5) 
Environmental Exposure: No significant relation of this 
mapped data to any policy or research advantages. (6) 
Health care services: There was significant relation of this 
data to accessibility policy. (7)Transportation Access: 
There is significant relation to accessibility policy as well 
as significant to generating etiology hypotheses. 
(1) The government must encourage the updating 
and use of diseases registries’ databases in 
mapping reports and help connect health research 
with politics environment (2) The GIS use 
depends on training the potential GIS end-users 
and disseminate the GIS technology. (3)Policy 
makers should be involved in health related data 
development, analysis, and GIS use (4) the policy 
makers should be motivated and educated about 
the importance of the GIS use in practice.
Rhobinson 
et al 2011/USA
To test and refine the 
online tool was 
developed to join and 
communicate the 
geovisualization and map 
developers experts
Online needs 
assessment survey 
with targeted end-
users 
The sampled public health 
professional participants were 
probed about the tested tool's 
learning artifact 
Current learning Habits: Most of the participants spend 
<10 hours learning on new tools. Some of them were asked 
to learn by the employer. The net, journal articles, 
scientific conferences, and asking others were good ways 
to learn. Searching the net is the common way which is 
used by them find tools’ learning artifacts. Other co-
workers are better than employers in offering information 
about tools. Most of them admitted the importance of GIS 
use in practice.  Preferred learning artifacts: Most of 
participants preferred having extensive tutorials and 
sessions on GIS technology’s content, summary, 
functionality, and usability.   >560% want to know the bio-
sketch and the credentials of the learning artifacts’ 
developers.  The artifact content and the summary are the 
most important parts, and the metadata was the least 
required thing.  Contributing Learning artifacts: 
Wikipedia, YouTube, and Facebook were the most 
important resources of learning. Almost all of the 
participants agreed on the importance of the learner’s bio-
sketch and credentials in motivating them to apply the 
artifact in practice.
The GIS tools end users should be involved in 
designing and development of the learning 
artifacts of these tools through needs assessment 
surveys
Bhowmick 
et al 2008/USA
To develop and test the 
new geographic 
information technology 
and tools to analyze and 
visualize the complicated 
health datasets in public 
health field
Key informant 
interviews on the 
use of GIS 
technology followed 
by a systematic 
review on the related 
literature
Sixteen cancer research experts 
were recruited through snow 
ball sampling technique.  Semi-
structured phone interviews 
were conducted using focused 
discussion and ACT-based 
representation of Knowledge 
(ARK) techniques. The GIS 
non-users were studied to find 
the barriers to use the GIS 
technology.
The participants had different demographic, experience, 
and scientific backgrounds.  Most of them were cancer 
research experts. Most of them pointed the importance of 
GIS in detect dataset features, generate hypotheses, and 
to discover roles of GIS in cancer dataset exploration. 
Most of them did not use sophisticated GIS technology, 
but some of them they mentioned a geospatial rules as 
routine work. The GIS technology use was recognized 
from moderately to a very useful in cancer research field. 
Usability testing studies are more productive than 
just interviewing public health practitioners or 
reviewing literature. In depth interviews of a small 
size samples are more productive than 
interviewing large samples in less depth. 
Collaboration between the information domain 
experts and the implementation experts is very 
important. 
Joyce 2009/UK
To assess the perception 
of the public health 
policy makers about the 
GIS use in public health 
field, advantages and 
disadvantages of GIS in 
public health field, and 
considering GIS 
technology as away of 
collaboration and 
exchange information
Semi structured 
interviews
Face to face interviews of 23 
PHPs participants, who were 
chosen based on specific 
selection criteria. 
GIS technology a producing knowledge, able to integrate 
and analyze databases. There are challenges to use GISs.  
GIS includes temporal-spatial information could search 
cause-effect theories. GISs are crucial for communication 
and collaboration between experts of the same interests. 
The linkage and willingness of sharing GIS technologies 
must be strengthened further. Most of the GIS end users 
afraid of the GIS complicated functions. GIS output 
impacts realities by relating the findings to real life 
parameters and could affect policy makers’ points of view. 
GIS information could be manipulated and misinterpreted. 
GIs tools becomes crucial in practice. The users 
should be helped and trained to adopt use the GIS 
in practice. GIS likely to be most effective in 
decision-making when applied in a multi-
disciplinary context to facilitate sharing of data, 
knowledge and expertise across the public health 
landscape.
Higgs 2005/UK
To search the types of 
organizational barriers to 
the fruitful operation of 
GIS within the National 
Health Services (NHS) in 
UK, and compare the 
findings to the previous 
related literature
 National survey 
followed by in-depth 
semi-structured 
questionnaire, 
followed with a 
systematic review
Grounded on a national 
questionnaire results, the 
researchers conducted semi-
structured interviews of 20 
NHS personnel. The interviews 
including these factors: 
individual issues, policy 
issues, data issues, 
organizational issues, and 
various resources issues. 
GIS use and implementation:  increase of GIS use after the 
survey’s conduction. Geospatial reports production and 
analysis are important in practice. Examples GIS uses: 
inequalities, accessibility, environment sciences. About 
half of the interviewees did not fully run their GIS. 
Information Technology administration and maintaining 
systems are essential to enhance GIS usability. GIS 
implementation barriers:  lack of electronic datasets, 
complicated GIS tasks, scarce trained resources, lack of 
maintenance systems, lack of clear organizational plans 
and goals, absence of external and central leadership on 
GIS, lack of alertness among clinicians and administrators 
of GIS technology. Levels of geographical information 
exchange: issues with certifying measures for data, 
inappropriate datasets, bad marketing of GISs, 
inappropriate interoperability between organizations.
The collaborated organizations which are tackling 
health issues should modify their cultural and 
organizational policies, to be able to exchange the 
health-related geospatial data.  This needs expert 
advice and guidence.
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The first study was conducted as a collaboration of three geography scientists from three 
different universities. The aim of the study was to analyze the important organizational 
issues which are important to successfully implement GISs within National Health 
Services (NHS) in the UK and compare the results to previous studies that were 
conducted to analyze the same aim. The study design was mixed-methods, starting with a 
national questionnaire followed by semi-structured interviews. The national questionnaire 
was formed on the current use of GIS software; future plans for GIS use; policy related 
uses of GIS; the barriers of using GIS; enumerate human, environmental, and 
organizational barriers to implement GIS. The questionnaire was answered by health 
services professionals. An in-depth interview was conducted on 20 selected NHS 
personnel. The interviews included the potential issues to establish GIS software, 
individual issues, policy issues, data issues, organizational issues, and various resources 
issues.  The national survey revealed an increase of GIS use, map production and GIS use 
in analysis, modeling, and data integration are important. The examples of GIS uses were 
in: inequalities, accessibility determination, and environmental sciences. Less than 50% 
of the interviewees stated they did not fully operate their GISs. Informational technology 
administration and maintaining systems are influential for GIS implementation. Both the 
survey and the interviewees stated a list of the obstacles to GIS implementation: lack of 
digital data, difficult analytical tasks of GIS, lack of staff resources to operate GIS, lack 
of GIS skills, lack of maintenance systems, lack of wide organizational planning, lack of 
authority’s awareness, insufficient training of the GIS users, lack of central plan and 
support from the department of health to its organizations, and lack of awareness among 
clinicians and administrators of the GIS importance. The respondents were asked about 
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the barriers and issues which restricted the geographic information exchange, the 
responses were varied: Licensing arrangement issues between the organizations, presence 
of GIS data in specific formats, lack of interest of GIS exchange in other organizations, 
and hard- and soft-ware incompatibilities among different organizations [20]. 
The second study was conducted by three communication and art scientists, and a public 
health scientist. The aim of the study was to evaluate the use and the utility of GIS tools 
in mapping cancer related data and their effect on cancer control policies and practice, 
and to measure the participants’ perception on using such tools in the Comprehensive 
Cancer Control (CCC) program.  The researchers recruited the participants through 
email. Forty-nine U.S. CCC program directors out of 50 states were interviewed by 
phone. The interview questions were to explore the relationship of GIS reports to public 
health policy and research. The identified advantages of using GIS on cancer policy were: 
Identify service gap, identify access issues, identify cancer staging, followed by identify 
risk population. The identified advantages of using GIS on cancer research were: 
multivariate modeling tool, monitoring and surveillance, followed by generate etiologic 
hypotheses. There was no significant relationship discovered between using behavioral 
risks mapped reports and research, while there was a significant relationship between 
behavioral risks mapping data and the policy of identifying the at risk population. The 
study did not discover any significant relationship of cancer burden mapped reports and 
cancer control policy, but there was a significant relationship of this kind of mapped 
reports and the generating etiology hypotheses research advantage. About 51% of the 
interviewed directors stated that the demographics are an important content of any 
mapped reports, but the study researchers could not find any significant relation of the 
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demographics to any of the policy and research advantages. There was significant 
relation of mapped reports of transportation access and the accessibility policy, and the 
etiology hypotheses research advantages. There were no significant relations between 
policy and research, and all of these kinds of cancer mapped contents: Environmental 
exposure, multi-layer content maps, and healthcare services [21]. 
The third study was conducted by scientists from the geography, environmental science, 
and public health fields. The aim of the study was to develop and evaluate the tools and 
methods that might be used by PHPs in order to extract knowledge and evidence from 
health-related databases. The methodology of the study was semi-structured phone 
interviews of 16 participants who were recruited using snowball sampling. The 
investigators searched the literature of using GIS in cancer research to support the 
interviews’ results. The study findings were: Most of the participants were faculty or 
senior administrators of different demographic and scientific backgrounds. They varied in 
experience. Most of the participants were involved in the cancer research domain. Most 
of the participants pointed that the typical goal of data exploration were to detect dataset 
aspects, to develop hypotheses for further cancer research, and to discover roles of 
geospatial methods in the exploration process. Most of them did not use complex spatial 
analysis, but 30% of them reported geo-coding, map creation, and GIS data analysis as 
regular research activities. GIS analysis were considered from moderate to very useful 
tools in cancer research, specifically in incidence and mortality cancer data. They pointed 
to the importance of GIS in comparing spatial data of different cancer types, disease 
clustering, correlation with related spatial indicators, and combining geospatial data from 
different domains. The participants pointed to the following limitations in GIS use: 
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difficulties in geo-coding and data aggregation, lack of support for merging data from 
different data sources and/or constructed with different GIS tools, complexity of GIS 
tools use and functionalities [22].  
The fourth article’s aim of the study was to study public health professionals’ perceiving 
of the GIS in practice and research and understand the impact of GIS on data sharing and 
communication. The methodology was face-to-face semi-structured interviews of 23 
participants of policy decision makers. The participants were recruited purposefully. The 
article findings are: GISs are converting raw data to useful data and knowledge. GIS has 
the ability to integrate and analyze datasets. GISs are important in public health practice 
and decision making, but include many implementation and usability challenges. GIS 
could be used to explore cause-effect relationship by including time and space, and have 
epidemiological power. GISs are crucial for collaboration between experts of the same 
interests but there are challenges to that. The linkage and willingness of sharing GIS 
technologies must be strengthened further. Most of the low experiences in GIS use of 
public health practitioners are fear of the sophisticated functions of the GIS tools. GIS 
output impacts realities and could affect policy makers’ decisions. Some participants 
pointed that GIS tools are not neutral and map makers might manipulate datasets using 
GIS power. Metadata and detailed text are very important to interpret the GIS data. Data 
quality is very important as well as strict standards during constructing GIS data. GIS 
tools are considered user-friendly, and easier to relate data tools. Time and resource 
constraints, training skills, and intra-organization environments enhance feelings of 
insecurity and concern among potential GIS end-users [23]. 
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The last article’s aim was to conduct a needs assessment survey on the potential end 
users of the Geo-visual Explication (G-EX) Portal, an online tool was designed to 
connect researchers in geo-visualization to the end users, to refine the G-EX Learn 
module. The researchers developed a web-based survey using their previous in-depth 
usability studies.  The participants were recruited by sending them emails. There were 
21 participants from different back grounds: Epidemiologists, health policy 
specialists, geographers, and research scientists. The results were as follows: Most of 
the participants spend less than ten hours per week learning new tools and 20% of 
them were required by their employers to keep learning these tools. The ways of 
learning about new tools were: the net, journal articles, conference sessions, and 
asking colleagues. The least likely way participants learned about these tools were 
advertisements and employer contribution. The participants’ preferred learning 
artifacts were comprehensive tutorials followed by hands on training. Most of the 
participants wanted the artifacts to include: expected training duration, summary of 
learning objects, and they preferred to start using the software before starting the 
training. 63% of the participants liked to know the biography of the trainers. Most of 
the participants spotted that the artifact’s content, summary, and the instructions are 
the most important parts of any learning module. The other contributing artifacts for 
the participants were: Wikipedia, YouTube, and social media respectively.  52% of 
them were interested in development training material to share with others on the G-
EX website [24].  
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Discussion 
The findings of the reviewed articles are discussed separately as they were classified in 
the methods and the results sections.  
Usability Testing Studies: 
It is important to include a representative sample of the actual users in any usability 
testing of any GIS tool. A five participants study is able to demonstrate most of the 
usability problems of the tested material [25]. This enables the investigators to measure 
the actual user- tool interface and helps them successfully design, implement, and refine 
these tested tools. All the studied usability testing articles used the actual users to test the 
GIS systems. The review also revealed that the usability testing research should extend to 
explore the content, functionality, and the utility of the GIS tools. The review stated that 
any GIS tool should be iteratively evaluated using different methodologies. The review 
discovered that case studies by collaboration with experts were very valuable in refining 
and development of GIS tools. The review concluded that visualizing the health-related 
data in an interactive way including tables, maps and graphs is considered the best way to 
present such information. The review revealed the importance of the development of 
online applications to access more potential users and help them participating in testing 
the GIS tools.  The review stated that building successful mapping reports depends on the 
availability of: monetary support, right data, and expertise in map construction. The 
Review pointed that the level of experience in using visualization data is critical on 
willing to use GIS software, and on interpretation and linking of the mapping reports’ 
information.  
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Usability Studies Based on Just Interviewing the Participants:  
The review revealed that even to assess the PHPs’ preferences and perspectives the 
researchers do not have to rely on just interviewing the participants, but they have to 
search for more methodology to support their results validity. Some of our reviewed 
articles supplemented their interviews with the results of well-respected national 
questionnaire, and some did systematic reviews to support the study evidence and 
generalizability.  
Health organizations should assess and overcome the organizational, cultural, technical, 
and expertise barriers to implement and use GIS software to visualize their data. One of 
our reviewed articles recommended the adoption of policies that support visualization of 
health related data on the state level, and valued the importance of state encouragement 
of utilization and presentation of disease registries on geographic bases to connect health 
research to the political environment. All of the reviewed articles pointed to the 
importance of dissemination of successful GIS technology, training the potential users 
adequately, giving up-to-date information technology administration support and 
maintenance. Most of the reviewed articles recommended involvement of policy makers 
in using GIS tools and in analysis of the GIS tools results. The review recommended 
collaboration between GIS software developers and implementers and the potential end-
users to develop new- and test the refined- versions of public health GIS tools.  
The review articles in this section revealed that needs assessment is crucial to know the 
perspectives of the GIS potential users and to develop web learning portals and modules. 
The review suggested that the learning artifacts of GISs tools could be presented in 
different formats based on users’ preferences. The review recommended that employers 
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must offer extensive training for their GIS potential users before and after 
implementation of the GIS tools.  
Conclusion 
In general, the review revealed that PHPs are alert about the importance of using GIS 
software on public health policy and research. Most of the studies’ participants pointed to 
the advantages of using GISs on public health practice in determining the inequalities, 
accessibility, and they stated the importance of supplementary roles of other contextual 
indicators on different public health problems when these indicators are visualized with 
the health-related data.  
Most of the studies revealed the participants were aware of the collaboration and the 
exchange of the GISs technology and data between the experts in the public health field, 
and the importance of including the end users in the basic stages of designing and 
development of the GIS tools.  Also, the importance of extensive evaluations for GIS 
tools before and after releasing them, and the essentiality of adequate training for the 
potential users of these GIS tools. 
Review Limitations and Future Directions 
The review’s authors searched a limited number of data bases, used strict inclusion and 
exclusion criteria, and used the literature which published in a limited period of time. 
Future usability testing studies must include more potential end users who must be 
recruited randomly and tested using more sophisticated methodology and more strong 
qualitative as well as quantitative measures.    
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Usability Assessment of the Missouri Cancer Registry’s Published 
Interactive Mapping Reports: Round one  
Abstract 
Background: Many users of spatial data have difficulty interpreting information in 
health-related spatial reports. The Missouri Cancer Registry and Research Center (MCR-
ARC) has produced interactive reports for several years. These reports have never been 
tested for usability. 
Objectives: To conduct a multi-approach usability testing study to understand ease of 
use/user friendliness/satisfaction and to evaluate the usability of MCR-ARC’s published 
InstantAtlas™ reports.  
Methods: Study Design: An Institutional Review Board (IRB) approved mixed 
methodology usability testing study using a convenience sample of health professionals. 
Participants: A recruiting email was sent to faculty in the Master of Public Health 
Program and to faculty and staff in the Department of Health Management and 
Informatics at the University of Missouri-Columbia. The study included seven (7) 
participants. Study Procedure: The test included a pretest questionnaire, a multi-task 
usability test, and the System Usability Scale (SUS). Also, the researchers collected 
participants’ comments about the tested maps immediately after every trial. Software was 
used to record the computer screen during the trial and the participants’ spoken 
comments. Measured Outcomes: Several performance and usability metrics were 
measured to evaluate the usability of MCR-ARC’s published mapping reports.  
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Results: Six of the ten assigned tasks reached a 100% completion success rate, and this 
outcome was relatively related to the complexity of the tasks. The simple tasks were 
handled more efficiently than the complicated tasks. The SUS score ranged between 20-
100 points, with an average of 62.7 points and a median of 50.5 points. The tested maps’ 
effectiveness outcomes were better than the efficiency and satisfaction outcomes. There 
was a statistically significant relationship between the subjects’ performance on the study 
test and the users’ previous experience with Geographic Information System (GIS) tools 
(P = .03). There were no statistically significant relationships between users’ 
performance and satisfaction and their education level, work type, or previous experience 
in healthcare (P > .05). There were strong positive correlations between the three 
measured usability elements. 
Conclusion: The tested maps should undergo an extensive refining and updating to 
overcome all the discovered usability issues and meet the perspectives and needs of the 
tested maps’ potential users. The study results might convey the perspectives of academic 
health professionals towards GIS health data. We need to conduct a second round 
usability study with public health practitioners and cancer professionals who use GIS 
tools on a routine basis. Usability testing should be conducted before and after releasing 
MCR-ARC’s maps in the future. 
Keywords: Geographic Information Systems, Health Professionals, Interactive Maps, 
Missouri Cancer Registry, Usability. 
Introduction  
Geographic Information System (GIS) tools should be planned to achieve the desires and 
perceptions of these tools’ targeted users. The development of GIS tools does not seem to 
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be an issue; the problem is in how to ensure that existing tools can be used more 
effectively and efficiently [1, 2].  
Health care and public health fields have started using sophisticated technology to 
analyze and visualize health-related data. Advanced visualization technology is becoming 
essential and important nationally and internationally to help control many health-related 
problems. This technology has positively impacted health-related research and policy 
development. Therefore, these databases need to be held wisely, investigated sufficiently 
in order to produce consistent results, not mislead the audiences, and produce the 
expected impact [3].  
As the previous literature has pointed out, high percentages of any new digital 
technology’s potential users find difficulties in interpreting and understanding the 
complicated and combined information [4, 5, 6]. For the GIS tools where statistical and 
spatial information are combined, the tools’ users have faced the same difficulties. 
Several reasons have been identified: inadequate experience and training on how to use 
this technology; lack of awareness among potential users; refusal to use this kind of 
technology; and because this technology is often vague, complicated and not user 
friendly [7].  
Static and interactive health-related mapping reports could generate knowledge, yield 
proof, and enhance policies [8]. Each interactive mapping report should convey an 
unambiguous purpose and transmit a flawless meaning to the addressees [9]. Targeting 
the health scientists and decision makers, the health-related maps should embrace 
references of the used data resources and the approach which was used to get the mapped 
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results. The usability of the health-related mapping reports must be accordingly 
scrutinized and assessed using a representative sample of the potential users before and 
after releasing the maps [3].  
The current scientific literature supports the importance of cooperation between public 
health scientists and health professionals in integrating health information from diverse 
sources via portals and applications. These systems can guide public health professionals 
in designing and developing useful public health policies and interventions [10]. Over the 
last two decades, the mapping reports have transformed from being static to being 
dynamic [11]. GIS users prefer interactive reports over static and animated ones [3]. The 
same literature encourages map developers to consider the practical and social issues of 
users during development, evaluations, and updates of GIS tools [12].  
Many cancer registries have started interactively mapping their databases’ results but few 
of them are assessing the usability and functionality of this technology [13, 14, 15, 16, 
17]. We are seeking to fill this gap and give an exemplary model to help other registries 
to conduct usability testing studies to tailor their visualized and mapped material 
according to their possible users’ perception and preferences. 
This study was the first usability study to assess the quantitative and qualitative metrics 
data from the sampled health professionals while they are interacting with the published 
MCR-ARC InstantAtlas™ mapping reports. The investigators conducted a multiple 
methodology usability testing study of the published interactive mapping reports of the 
Missouri Cancer Registry and Research Center (MCR-ARC). The goals were to 
understand the ease of use/user friendliness/satisfaction of the maps, and to measure their 
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effectiveness and efficiency using a convenience sample of health professionals. These 
maps had been implemented with InstantAtlas™, See Multimedia Appendices 1 and 2 
[18, 19]. The study aims to refine the registry’s published reports to increase the 
satisfaction of their professional end-users. The investigators also want to assess whether 
and to what extent, the users’ performance will be affected by their demographics, 
experience, education level, and type of work. 
Methods 
Study Design 
The investigators chose a mixed methodology approach. The tested reports had been 
published on the MCR-ARC website [20]. The researchers conducted a pretest 
questionnaire, a multi-task usability test, and the System Usability Scale (SUS) for every 
participant [21]. 
The Pretest Questionnaire 
The questionnaire included questions on every participant’s work type, personal 
information, total experience in the public health field, experience in use of GIS tools, 
years of practicing public health, and the participant’s education level (see Multimedia 
Appendix 3). This step was followed by the multi-task test.  
Multi-task Usability Test 
The multi-task usability test was composed of ten individual tasks, which were applied on 
the tested mapping reports. These tasks were performed by the participants to diagnose 
the usability of the tested reports. Based on the published mapping reports functionality, 
the multi-task usability test was constructed by the study investigators to measure the 
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efficiency and effectiveness of the tested reports. The tasks were in the same order for all 
participants (see Multimedia Appendix 4). There were ten because these assigned tasks 
covered most of the maps’ functionality. By conducting all these tasks effectively and 
efficiently, the users could reach the designer’s expected beneficial of our visualized data 
The System Usability Scale (SUS) 
The System Usability Scale is an industrialized and simple ten-item scale to measure the 
participants’ subjective evaluation of the tested mapping reports’ usability. The SUS was 
conducted immediately after the completion of the multi-task usability test. The SUS 
scores range between 0 and 100. Scores above 68 points have been counted as acceptable 
according to usability literature and higher scores represent the optimal to best score [21].  
Participants 
The study’s proposal was approved by the Health Sciences Institutional Review Board 
(IRB) of the University of Missouri-Columbia. Recruiting emails were sent to faculty in 
the Master of Public Health (MPH) Program and faculty and staff in the Department of 
Health Management and Informatics (HMI) at the University of Missouri-Columbia. 
Using a convenience sample, investigators ran the study’s trial on the first seven potential 
respondents who agreed to participate. The minimum number of participants needed to 
conduct a successful usability study is five; a five-participant study will be able to 
demonstrate between 55% -100% of the usability problems of tested material [22, 23]. In 
this study, we increased the number to seven subjects to catch more usability issues of 
our tested reports [24].  
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 Study Procedure 
Every participant tried ten tasks in a safe and private space for an average of 30 minutes 
per participant. The researchers used a computer laptop to conduct the trial. Windows 
Media Player software was installed to record the screen while the participants took part 
in the trial as well as their spoken comments. Task completion time and task completion 
success were analyzed manually based on the recordings.  
The following outcomes were measured: 
Performance Metrics 
A few metrics were utilized to assess the effectiveness and the efficiency of the tested 
mapping reports and to uncover usability problems. Some of these metrics are defined in 
terms of critical errors—an error which resulted in an incorrect or incomplete task. If a 
participant sought help from the test observer to finish a task, it was considered to be a 
critical error [25]. The investigators measured the following metrics:  
1. Effectiveness: Task Completion Rate (TCR). TCR is a measure of tasks that were 
completed without critical errors, and the outputs of the task were correct [24, 25]. 
TCR represented the mapping reports’ usability effectiveness and was analyzed in 
two distinct ways: by participant and by task. 
a. TCR per participant: The percentage of tasks that were successfully 
completed by a participant [25].  
TCR	per	participant ൌ Number of tasks completed successfully
Total number of tasks undertaken
∙ 100% 
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b. TCR per task: The percentage of participants who successfully completed 
a given task [25].  
TCR	per	task ൌ Number of participants	who completed successfully
Total number of participants
∙ 100% 
 
2. Efficiency: The resources expended in relation to the “accuracy and completeness 
with which users achieve goals” [26]. Using the video records, the time per task 
was measured from the beginning of the task until the time of start doing of the 
next task.   
The investigators calculated the efficiency and the productivity of the tested 
mapping reports using the following metrics: 
Time Based Efficiency (TBE) per Task. This is a task-specific version of an overall TBE 
as defined in [20]. 
തܲ௧,௝ ൌ 1ܰ෍
݊௜௝
ݐ௜௝
ே
௜ୀଵ
 
  
Overall Relative Efficiency (ORE) per Task. This is a task-specific version of an 
overall TBE as defined in [25].  
തܲ௝ ൌ
∑ ݊௜௝ݐ௜௝ே௜ୀଵ
∑ ݐ௜௝ே௜ୀଵ ∙ 100
 
 
where 
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ܰ ൌ Total number of tasks 
ܴ ൌ Number of study subjects 
݊௜௝ ൌ Result of task ݅ by user ݆ 
ൌ ቄ1 if the user successfully completes the task0 otherwise 	
ݐ௜௝ ൌ The time spent by user ݆ on task ݅. 
User Satisfaction 
Overall satisfaction per study subject was measured by the SUS survey. See the details 
under study design section. 
Factors Affecting the Participants’ Performance 
Before conducting the study, the current study researchers expected that there are some 
factors that might impact the participants’ performance and their satisfaction on the tested 
maps and we assessed the influence of these elements on the participants’ performance. 
These factors were the participants’ education level, work type, experience in healthcare 
field, and previous experience with mapping reports and GIS tools [27]. The investigators 
used a variety of statistical methods, as needed, to explore these relationships (Wilcoxon-
Mann-Whitney test, Pearson correlation, and simple linear regression). The Wilcoxon-
Mann-Whitney test was conducted using the web implementation of the method 
described in [28]; the remaining analyses were conducted using Excel. The intended 
sample size of this study was small since we primarily wished to uncover major usability 
problems; post-hoc power calculations for simple linear regression with the observed 
sample data indicates that the power for testing the relationships between the participants’ 
factors and the TCR or SUS ranged between 3% and 24% [29]. We used a type I error 
rate (α) of .05 for the hypothesis tests conducted in this project.  
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Results 
1. Participant Demographics 
Seven health professionals were interviewed: one white male and six white females. 
Their ages ranged from the early 30s to late 60s (mean = 49.57 years, median = 49.17 
years). Three of the seven participants were from the MPH program and four from the 
HMI department. Four hold a doctoral degree in a healthcare related field and three have 
a master’s degree in public health or in health management and informatics. Five of the 
seven participants were working as research or teaching faculty. Two participants were 
both staff members and doctoral students in the health informatics program, and working 
in cancer and/or public health research; both had experience in working with mapping 
reports for at least one year. All seven participants have had experience in healthcare 
field, ranging from 3 to 38 years (mean = 17.8 years, median = 13 years). The 
participants’ total experience in using mapping interactive reports at work ranged 
between a few months to 15 years (mean = 5.6 years, median = 2 years). Our 
participants’ work types can be classified, according to their daily work roles, into two 
broad categories: Faculty and analysts (n = 5), and directors and staff (n = 2). 
2. Reports’ Effectiveness and Efficiency 
The Mapping Reports’ Effectiveness 
Effectiveness per Participant 
A PhD holder participant, who has 13 years of experience in the public health field and in 
GIS use, could not accomplish two of the assigned tasks because she “had no idea how to 
navigate them” as she commented. Three of the remaining six participants were not able 
to follow expected pathways to finish the assigned tasks and got false results for some 
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tasks. These participants thought that they completed the tasks successfully and did not 
ask for help or clarification. One of the three participants is a PhD-holding faculty 
member and the other two are staff members. All three participants had one to six years’ 
experience using GIS tools. Of the remaining three participants, all were able to complete 
the tasks effectively and efficiently, including one who had the least amount of 
experience with mapping reports and tools of the seven participants.  
The effectiveness was defined as: “The accuracy and completeness with which users 
achieve specified goals” [26]. The results in our study ranged from 70% to 100%, with 
only one participant finishing the trial with a TCR < 78% (Figure 1), the minimum score 
accepted by some scholars [25].  Four of the seven subjects attained a TCR of 90% or 
more.  
 
Figure 1. Task Completion Rate (TCR) per Participant. [Note: Dark Gold Indicates 
Participants Who Finished the Trial with ≥ 78% TCR; Red Indicates Participants Who 
Finished the Trial with < 78% TCR.] 
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Effectiveness per Task 
The investigators used the task completion formula to measure the TCR by task. The 
results are shown in Figure 2. Six of the ten assigned tasks reached a TCR of 100% and 
two of the ten tasks had a TCR of 90% while one task had a TCR of 80% and the 
remaining task had a TCR of 70%.  
Task #s 1, 2, 7, 9, and 10 were very simple, such as open or close a functional button on 
the reporting map. All had a TCR of 100%. 
Tasks #3, 4, 5 & 8, got the lowest TCR, with scores ranging between 70% and 90%. 
Before conducting the current study, the study investigators ranked task #s 3, 4, 5, and 8 
along with task #6 as complicated tasks that need specific skills and knowledge to be 
completed successfully. One complicated task, #6, was completed effectively by all 
subjects.  
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Figure 2. Task Completion Rate per Task. [Note: Blue Indicates Tasks Involving the 
Area Health Profile (Tasks 1–6); Red Indicates Tasks Involving the Double Map (Tasks 
7–10). Light Blue Indicates Tasks That Had > 78% TCR; Dark Blue Indicates the Task 
(Task 5) with < 78% TCR. 
Mapping Reports’ Efficiency and Productivity: 
The time per tasks ranges from the minimum two seconds for task #10 to the maximum 
297 seconds for task #8 which includes three subtasks. As seen in Table 1, even among 
the tasks with a 100% completion rate, there was variation in the time spent by the 
participants. The median time on task #6 was the highest, followed by tasks #8, 5, 4, and 
3 respectively and this was relatively related to the complexity of the tasks. 
Table 1. Time on Study Tasks 
Task # Task Time Range Task Time Mean Task Time 
Median 
1 3-62 seconds 19.4 seconds 12 seconds 
2 10-51 seconds 23 seconds 16 seconds 
3 13-64 seconds 34.8 seconds 33 seconds 
4 20-87 seconds 57 seconds 53 seconds 
5 11-268 seconds 95.8 seconds 75 seconds 
6 46-215 seconds 136 seconds 145 seconds 
7 2-20 seconds 11 seconds 11 seconds 
8 90-297 seconds 165.1 seconds 141 seconds 
9 3-16 seconds 41.5 seconds 21 seconds 
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10 2-38 seconds 3.2 seconds 3 seconds 
 
Time Based Efficiency (TBE) and Overall Relative Efficiency (ORE): 
Figures 3 and 4 show the Time Based Effeciency (TBE) and the Overall Relative 
Effeciency (ORE) for each of the tasks. 
 
  
Figure 3. Time-based Efficiency (TBE) per Task  
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Figure 4. Overall Relative Efficiency (ORE) per Task. [Note: Purple Indicates Tasks 
With 100% ORE per Task; Dark Tan Indicates Task with Less Than 100% ORE per 
Task] 
From Figure 3, we can see that the TBE per task varied for the ten tasks. Task #10 had 
the highest TBE (19.2 goals/minute); this result conforms to the simplicity of the task 
(close the map). It is followed by tasks #7, 9 and 1, which are also simple tasks (proceed 
to the “double map” link on the desktop, open the “area profile” map link in the desktop, 
and check the sources of our mapping report data, respectively. Tasks #2, 3, and 4 all 
complicated tasks and had very low TBE rates. Tasks #5, 6, and 8 were the most 
complicated tasks; they had the lowest TBE levels. 
Figure 4 shows that the highest ORE rates were for tasks #1, 2, 9 and 10; they were all 
simple tasks. Task #6 had about 97% ORE rate despite it being ranked as one of the 
complicated tasks. Tasks #3, 4, 5, and 8 had the lowest ORE per task. 
0
10
20
30
40
50
60
70
80
90
100
1 2 3 4 5 6 7 8 9 10
O
ve
ra
ll 
R
el
at
iv
e 
E
ff
ic
ie
nc
y
Task Number
Overall Relative Efficiency per Task
   130
3. Users’ Satisfaction 
SUS is a standard ten-question questionnaire given to every participant after the tasks to 
measure the user satisfaction with the tested maps [20]. The SUS score range for all the 
participants was 20-100 points with an average of 62.86 points and a median of 50.50 
points. The SUS scores for three of the seven study participants were above the target of 
68 points and they were satisfied with the maps they tested. The remaining four of our 
participants’ scores were below 68 points. The interpretation of the SUS scores for the 
study subjects ranged between worst imaginable to best imaginable, and according to the 
school grade scale, the scores were between A and F with an average of D.  
 
 
Figure 5. System Usability Scale (SUS) Scores of the Study’s Participants. [Note: Brown 
Color Indicates SUS Score of ≥ 68 Points, and Blue Color Indicates SUS Score of < 68 
Points] 
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4. Factors Affecting the Participants’ Performance: 
As discussed in the methods section, we expected that there are some factors could 
impact the participants’ performance and their satisfaction on the tested software.  
Education Level and Work Type Factors 
We assessed whether the education level of the participants impacted the distribution of 
either their TCR or SUS score using the Wilcoxon-Mann-Whitney test [27]. We 
classified the participants to PhD and Master Degree holder subjects and we tested these 
two groups’ TCR. We did not find any statistically significant difference in the 
distribution of the TCR by education level (P = .91). Also, there was no statistically 
significant difference in the distribution of the SUS score by education level (P = .82).  
The Wilcoxon-Mann-Whitney test was used also to assess whether the participants’ 
distribution of TCR differs by their work type. We categorized the participants into two 
groups: the faculty and analysts group and the staff and directors group. The difference in 
the distribution of TCR between the two groups was statistically insignificant (P = .75).  
Experience in the Healthcare Field and Experience with Mapping Reports and GIS 
Tools 
We conducted simple linear regressions to explore the relationship between the TCR of 
the study subjects on the usability test and between both the experience in healthcare field 
and the previous experience with mapping reports and other GIS tools. The relationship 
between the TCR and the experience in the healthcare field was insignificant (P = .70). 
There was a statistically significant relationship between the subjects’ TCRs and 
experience in GIS tools (P = .03). There was no statistically significant relationship 
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between the SUS levels and the previous experience with healthcare field or with GIS 
tools for the study participants. The P values for these results was (P = .82) and (P = .17) 
respectively. 
Table 2 has the results from studying the demographics and experience in the healthcare 
field and experience with GIS tools versus their TCR and SUS scores of the trials they 
performed in this study.  
Table 2. Demographic and Previous Expertise Factors of the Study Participants Versus 
the Trial’s TCR and the Participants’ SUS Scores  
The Studied Factors P 
Education Level vs TCR  .91 
Education Level vs SUS score .82 
Work Type vs TCR .75 
Previous Experience in 
Healthcare Field vs TCR 
.70 
Previous Experience in GIS use 
vs TCR 
.03 
Previous Experience in 
Healthcare Field vs SUS Score 
.82 
Previous Experience in GIS use 
vs SUS Score 
.17 
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5. Correlation between the Studied Usability Elements (Effectiveness, 
Efficiency, And Satisfaction) 
As Table 3 shows, we studied the relationship between the TCRs and the SUS scores and 
this revealed a positive, but statistically insignificant, correlation between the two studied 
factors (r = .70, P = .08). The relation between the TCR and both the TBE and the ORE 
factors were explored. The results revealed that there were positive correlations between 
the effectiveness (TCR) and both the efficiency in terms of TBE (albeit statistically 
insignificantly) and ORE (statistically significant) for the studied maps (r = .50, P = .25 
and r = .92, P = <.001 respectively). There was a positive, but statistically insignificant, 
correlation between the time spent by the participants for all tasks and the SUS scores 
they gave after they finished the test. The correlation was positively strong (r = .70, P = 
.07). 
Table 3. Correlation between the Studied Usability Elements (Effectiveness, efficiency, 
and Satisfaction) 
The Studied Factors Correlation Coefficient P 
TCR per participant 
vs SUS Score 
.70 .08 
TCR per task vs TBE .50 .25 
TCR per task vs ORE .92 <.001 
Efficiency per 
participant*  vs SUS 
Score 
.70 .07 
*: The total time in seconds of the whole trial per participant 
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Discussion 
Main Findings 
The current study concluded that the tested maps should undergo extensive refining using 
user-centered approach to overcome the discovered usability issues. This approach could 
enable map designers to facilitate good user-software interaction and usability. This will 
let the designers meet their maps’ potential users’ expectations [30]. Usability testing 
studies should be conducted before and after releasing the maps to their potential users. 
Effectiveness and Efficiency 
Effectiveness per Participant 
In any usability study, the investigators should always aim for a 100% as a TCR per 
participant; however, some usability scholars consider a TCR of ≥ 78% per participant 
acceptable [25].  Six out of the seven participants exceeded the target TCR per participant 
(78%), and just one participant out of the seven got a rate less than 78% (Figure 1). These 
results reveal that the trial was carried out effectively by six of the total seven 
participants.  Surprisingly, a PhD holder participant with plenty experience in the public 
health field and in GIS use could not accomplish two of the assigned tasks while other 
participants with lower education and null experience handled the trial effectively.  
Three participants incorrectly thought that they had effectively completed some tasks 
because there were no alerts or pop-ups to make them aware that they made mistakes. 
Some tasks were not dependent on each other, so the participants were not interrupted if 
the task was wrongly handled. Also, some of these tasks need to be answered by writing 
on paper and needed specific cognition and knowledge to be answered. 
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Effectiveness per Task 
Our results support the scientific evidence from a study conducted in 2006, which 
concluded that the technology effectiveness is affected by task complexity factor [31]. 
Task #s 1, 2, 7, 9, and 10 were very simple, such as open or close a functional button on 
the reporting map. These tasks did not require that participants find or interpret 
complicated epidemiologic or statistical results so all the participants were able to 
complete these tasks successfully. 
All the subjects accomplished task #6 effectively although it is categorized among the 
trial’s complicated tasks. This could be due to the study subjects’ previous experience in 
public health and health care, and/or all the subjects were epidemiologists and/or 
researchers familiar with biostatistics and epidemiology. Additionally, it may be because 
the task is very connected to the preceding tasks and it was very easy to accomplish when 
they solved the previous tasks.  
Not surprisingly, the remaining complicated tasks, #s 3, 4, 5 and 8, received the lowest 
TCR scores. Participants who lacked specific skills and knowledge were unable to 
complete these tasks successfully.  
According to the study subjects’ comments and by reviewing the recorded trial videos, 
additional usability issues with the published maps were revealed. These usability 
problems explained why these tasks were hard to be accomplished even with expert 
participants in public health, health field, and in GIS tools use. The maps’ designer has 
refined the maps according to comments made by the participants, and we re-released the 
maps. 
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Efficiency 
From Table 1 we determined that even for the tasks which were ranked easy and non-
complicated, some study subjects took more time and effort to get the tasks successfully 
conducted than the others, and this might need usability adjustment by the tested maps’ 
designer in the future to make these tasks able to be completed by all users within 
comparable times.  
From the TBE results (Figure 3), we expected that in addition to the cognition and 
knowledge which are needed to accomplish these tasks, the usability issues we 
discovered in the current study might make these tasks even more complicated than the 
investigators thought. The ORE results supported previous literature’s findings that the 
efficiency is relatively associated with the complexity of these tasks [31]. 
After reviewing the recorded videos, the primary investigator concluded that task #6 was 
easy to handle by the study subjects because it was closely related to its preceding three 
tasks. The study’s audio-video recordings revealed that repeating and re-trying the 
foregoing tasks allowed task #6’s to be accomplishment by all the participants.  
Participants’ Satisfaction 
Based on the SUS scores, we demonstrated that we have to consider our participants 
comments and refine our tested maps in order to make all our potential users more 
satisfied and pleased.  
We were surprised that many of the SUS scores were very low; this reinforces the need to 
test systems on potential users rather than assuming that they find the system usable. To 
improve the user satisfaction, we are willing to consider all the participants’ comments to 
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refine the tested maps. User surveys already were available on the reports to assess the 
users’ satisfaction and collect their feedback on using the mapping reports. The study 
investigators have acted on doing renovation on the current surveys according to the 
current study participants’ comments, but this remodeling still has not resulted in much 
feedback so far. All of the mentioned modifications could improve the evaluated reports 
and might make the polished reports more understandable and usable, and could increase 
the users’ satisfaction [32]. 
Factors Affecting the Participants’ Performance 
As the study researchers expected, there was a statistically significant relationship 
between the subjects’ TCRs and their experience in using GIS tools. So, there is 
dependency of the TCRs on the participants’ previous experience with GIS technology. 
This finding supports the findings of two previous studies revealing that the performance 
of users on a specific technology are related to previous exposure to that technology [27, 
33]. Also, these results supported previous findings of several studies concluding that 
experience and knowledge affects the task success rates of the tested technology [34, 35]. 
The investigators did not find any statistically significant relationship between the 
education level in terms of the graduate degree the participant holds and the participants’ 
TCRs. There was no statistically significant relationship between the participants’ 
education level and their SUS scores. The relationship between the participants’ TCRs on 
the test and their work type was statistically insignificant. The relation between the 
participants’ TCRs and between their experiences in healthcare field was statistically 
insignificant. The study failed to discover any statistically significant relationship 
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between the SUS levels and both the TCRs and the previous experience with GIS tools 
for the study participants.  
Correlation between the Studied Usability Elements (Effectiveness, Efficiency, and 
Satisfaction) 
The results revealed strong correlation between the three usability elements. The results 
support our assumption that the user will be satisfied if they can conduct the trial 
effectively and efficiently.  
Strengths and Limitations of the Study 
This is the first usability study to assess published MCR-ARC InstantAtlas™ reports. 
This is a good first step; these results might be generalized to assess the usability of all 
MCR-ARC’s mapping reports as well as GIS reports published elsewhere.  
The seven participants were all health professionals from academic departments. The 
small sample size coupled with the use of a non-probability convenience sample of 
academic health professionals limits the generalizability of these results.  
The video records were reviewed manually by one of the investigators. The current study 
could not capture all the performance and behavior of the participants while they were 
interacting with the tested maps. A better way to capture participants’ awareness and 
cognitive processes would be to make use of an eye tracking system. The investigators 
are thinking of using advanced usability software to track user behavior in the future. 
Ongoing Work and Recommendations  
The investigators conducted a second round of the usability study using professionals 
who are working directly in day-to-day cancer research and policy after a revision to the 
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maps based on the findings of this first round. The researchers assumed that second round 
professionals might have more valuable perspectives and insights towards the tested GIS 
reports. The investigators conducted the second round study after considering the first 
round participants’ responses and suggestions. All the future MCR-ARC mapping 
reports’ usability should be assessed during the designing process and after publishing the 
maps. The investigators should use advanced usability tools to test the published maps.  
Conclusion 
The three main elements of the tested mapping reports’ usability were measured and 
assessed by the current study in terms of: effectiveness, efficiency, and user satisfaction. 
The tested maps’ effectiveness outcomes were better than the efficiency and satisfaction 
outcomes. The trial was conducted effectively by six of the total seven participants. The 
study discovered that the effectiveness and efficiency metrics were related to the given 
tasks’ complexity, the easier tasks were accomplished more effectively and efficiently 
than the complicated tasks. Although most of the study subjects accomplished most of the 
tasks effectively and efficiently, the users’ satisfaction was surprisingly poor.  
The current study revealed that there was a statistical significance relationship between 
the subjects’ performance on the study test and the experience in GIS tools.  
The study researchers discovered that the pretest questionnaire and the multi-task 
usability test were not enough to discover all the usability issues of the tested maps. 
Seeking users’ text comments and analyzing the video recordings are very valuable to 
explore more usability concerns and to reveal the potential users’ preferences and 
perspectives towards GIS tools and maps. The study revealed that in order to facilitate 
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good map-user interaction and usability, the designers have to conduct usability trials on 
the maps including the maps potential users before and after publishing them.  
The current study results might be generalized to other mapping reports, and might be 
used to refine the usability and the functionality of these reports as well as other GIS 
reports and tools of the MCR-ARC. The study findings might point the importance of 
including the GIS tools’ end-users in the basic stages of designing and development of 
the GIS tools. 
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Usability Assessment of the Missouri Cancer Registry’s Published 
Interactive Mapping Reports: Round Two 
Abstract 
Background: Health-related data’s users have trouble understanding and interpreting 
combined statistical and spatial information. This is the second round of a usability study 
conducted after we modified and simplified our tested maps based on the first round’s 
results.  
Objectives: To explore if the tested maps’ usability improved by modifying the maps 
according to the first round’s results 
Methods: We recruited 13 cancer professionals from National American Central Cancer 
registries (NACCR) 2016 conference. The study involved three phases per participant: A 
pretest questionnaire, the multi-task usability test, and the System Usability Scale (SUS). 
Software was used to record the computer screen during the trial and the users’ spoken 
comments. We measured several qualitative and quantitative usability metrics. The 
study’s data was analyzed using spreadsheet software. 
Results: In the current study, unlike the previous round, there was no significant 
statistical relationship between the subjects’ performance on the study test and the 
experience in GIS tools (P = .17 previously was .03). Three out of the four (75%) of our 
subjects with a bachelor’s degree or less accomplished the given tasks effectively and 
efficiently. This study developed a comparable satisfaction results to the first round 
study, despite that the previous round’s participants were highly educated and more 
experienced with GIS. 
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Conclusion: By considering the round one’s results and by updating our maps, we made 
the tested maps simpler to use for subjects who have little experience in using GIS 
technology, and have little spatial and statistical knowledge. 
Keywords: Geographic Information Systems, Interactive Maps, Missouri Cancer 
Registry, NAACCR, Usability 
Introduction 
There are enormous Geographic Information System (GIS) technologies that have been 
created and designed to visualize different kinds of health and health-related data.  These 
tools should be designed and modified to meet the perceptions and needs of these 
technology’s possible users [1].  Software developers and designers, as well as the GIS 
technology innovators should concentrate on how to make this technology effective and 
efficient for the targeted users [2, 3].  
Public health professionals have started using specific advanced software to examine and 
illustrate population based databases. Illustrating and visualizing this kind of information 
becomes essential and important to make a measurable impact on the public health 
problems in any community. This type of technology has been influential on public 
health research, as well as on development of new effective public health policy.  
Therefore, we have to be sure that the population based databases are: Analyzed 
intelligently and examined appropriately to yield reliable outcomes, and that the results 
do not mislead the targeted audiences [4].  
The previous usability literature pointed out that most of any new numerical technology 
users face difficulties in interpreting the combined and multiple sources data [5, 6, 7]. 
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The same difficulties have challenged new GIS tools because of the combined 
geographical and statistical data of these tools. The scientifically proven interpretation 
was: Insufficient knowledge and inadequate hand-on experience  using GIS tools, 
ignorance and a decline to practice this technology between its prospective users, and 
because there were usability issues and complexity perception among the possible users 
towards this kind of technology [8].  
As previous scientific research revealed, regular and interactive mapping reports can 
produce knowledge, create evidence, and augment strategies [9]. Therefore, every 
interactive mapping report should carry a clear aim and convey a definite message to the 
targeted audiences [10].  These interactive maps must include citations and details of 
used information resources and the detailed methodology which followed the production 
of visualized results. The GIS technology related literature revealed that the mapping 
reports should undergo strong scrutiny and evaluation, using representative samples of 
the users, to assess the usability and make this technology fit the users’ needs and 
preferences [4]  
The collaboration between public health experts and the other specialists of the same 
research and practice interests has been proven scientifically and this relation’s positive 
impact on the public health problems and disparities has been confirmed [11]. Using 
highly advanced and sophisticated GIS tools will help public health experts to plan and 
create cost-effective, health-related strategies and policies [11]. During the third 
millennium, the health related maps have changed from being static to be interactive [12]. 
The scientific literature discovered that the GIS technology users prefer dynamic 
interactive maps [4]. The same literature concluded that the atlas creators need to take in 
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their account the potential users’ preferences and perceptions. The map developers should 
consider the users’ needs starting from the planning and designing processes, and ending 
by evaluating the maps before and after releasing them to the actual users [13].  
In the first round of the study, the investigators conducted a usability testing trial to 
assess the usability of the two published Missouri Cancer Registry and Research Center 
(MCR-ARC)’s interactive reports. The first round’s participants were faculty and staff of 
Master of Public Health program (MPH) and the Department of Health Management and 
Informatics (HMI) at University of Missouri-Columbia.   
In the current study, we conducted a second round of the same first round’s methodology 
to measure effectiveness and efficiency of the published InstantAtlas™ reports of MCR-
ARC. In this round, we selected a convenience sample of cancer professionals who 
attended the North America Association of Central Cancer Registries (NAACCR) 
conference-June, 2016. The current study investigators refined MCR-ARC’s published 
mapping reports based on the first round study’s results trying to meet the satisfaction of 
their professional end-users. The second round of study also aims to evaluate if and to 
what extent the users’ action will be influenced by the users’ demographic information, 
experience, education level, and the work type. 
Methods 
Study Design 
 The investigators selected a mixed methodology tactic. The tested mapping reports are 
already published on the MCR-ARC website as: An Area Profile and a Double Map 
including cancer, behavioral, and demographic indicators on Missouri counties level (see 
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Multimedia Appendices 1 and 2) [14, 15].  The trial elements were the same Round 
One’s components: A pretest questionnaire, the multi-task usability test, and the System 
Usability Scale (SUS) per every participant respectively [16].  
The Pretest Questionnaire 
The questionnaire involved inquiries on every subject’s age, race, work type, education 
level, total experience in public health field, and experience in GIS tools use (see 
Multimedia Appendix 3). 
Multi-task Usability Test 
This stage included ten independently ranked tasks, which were applied on the tested 
maps. These tasks were handled by the study subjects individually to test the usability of 
the tested InstantAtlas™ reports. The multi-task scenario was constructed by the study’s 
investigators grounded on the anticipated functionality of the tested maps. This phase 
aimed to precisely estimate the efficiency and effectiveness in terms of task completion 
success rate and task completion time [17]. All the tasks were in the same classification 
and context for all subjects (see Multimedia Appendix 3). 
The System Usability Scale (SUS) 
This phase was composed of a manufacturing and simple ten-item scale to assess the 
subjects’ independent assessment of the experienced mapping reports’ usability. This 
phase was immediately conducted after the multi-task scenario phase. The SUS score 
range is between 0 and 100. Sixty-eight or above has been considered as satisfactory 
based on previous usability literature and upper score up to 100 is the optimum to finest 
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score [16]. Scores above 68 points are acceptable according to usability scholars and 
higher scores represent the optimal to best score [16]. 
Participants 
The current study’s primary investigator attended the NAACCR-2016 conference and she 
convinced group of attendees to participate in the study and conduct the study’s trial.  
The convenience sampling method was selected to collect the current study’s 
participants. The investigators conducted the study’s experiment on the first reacted 
thirteen participants. As the usability scholars confirmed, five was the smallest number of 
subjects to run a fruitful usability study; a five subjects study enables revealing from 55 
to 100% of the usability issues of any experienced material [18]. The investigators 
increased the number to thirteen subjects to expose as many as probable of the usability 
issues of our refined published mapping reports [19, 20].  
Study Procedure 
A specific computer laptop was used to conduct the study. The researchers installed a 
Microsoft Windows-7 software, Windows Media Player, to audio-video record the 
laptop’s screen while the subjects performing the experiment. Every subject conducted 
the study trial in a secure and private area for an average of 30 minutes per subject. Task 
on time and task completion success rate were analyzed manually by the primary 
investigator based on the experiment’s audio-video laptop screen records.  
The subsequent usability metrics were also measured: 
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Performance Metrics 
These measures are the finest metrics to evaluate the effectiveness and the efficiency and 
to reveal the usability issues of the experienced interactive mapping reports. There are 
some definitions used in the current study to make the results and the measures more 
explainable: The critical error is the error which will result in an incorrect or incomplete 
task. If the participant will consider seeking help from the test observer to finish any of 
the trial’s tasks, we will consider that as a critical error [21]. The non-critical error is the 
error will have influence on the final output of the task and impacts the task’s efficiency 
[21]. The investigators measured the following metrics:  
1. Effectiveness, Task Completion Rate (TCR):  According to ISO-9241, the 
usability experts defined the usability effectiveness as: “The accuracy and 
completeness with which users achieve specified goals” [22].  
a. TCR per participant: The percentage of tasks that were successfully 
completed by a participant [21].  
TCR per participant ൌ Number of tasks completed successfully
Total number of tasks undertaken
∙ 100% 
 
b. TCR per task: The percentage of participants who successfully 
completed a given task [21].  
TCR per task ൌ Number of participants who completed successfully
Total number of participants
∙ 100% 
 
2. Efficiency: The efficiency is defined according to the ISO-9241 as: 
“Resources spent by user in order to ensure accurate and complete 
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achievement of the goals” [22]. The investigators calculated the efficiency and 
the productivity of the tested mapping reports using the following couple of 
formulas 
a. Time Based Efficiency (TBE) [21] 
തܲ௧,௝ ൌ 1ܰ෍
݊௜௝
ݐ௜௝
ே
௜ୀଵ
 
b. Overall Relative Efficiency (ORE) [21] 
തܲ௝ ൌ
∑ ݊௜௝ݐ௜௝ே௜ୀଵ
∑ ݐ௜௝ே௜ୀଵ ∙ 100
 
ܰ ൌ Total number of tasks 
ܴ ൌ Number of study subjects 
݊௜௝ ൌ Result of task ݅ by user ݆; 		݊௜௝
ൌ ቄ1 if the user successfully completes the task0 otherwise 	
ݐ௜௝ ൌ The time spent by user ݆ on task ݅. 
 
 
User Satisfaction 
SUS scale was used to assess the satisfaction per study subject. See the detailed SUS 
mechanism under the study design section. 
Factors Affecting the Participants’ Performance 
The current study researchers measured some factors that they expected might impact the 
participants’ performance and satisfaction during the trial. Those factors were: the 
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participants’ education level, work type, experience in healthcare field, and previous 
experience with mapping reports and GIS tools.  The investigators chose different 
statistical measures, as needed, to assess the chosen factors’ relationships (Wilcoxon-
Mann-Whitney test calculator [23], Pearson correlation test, and/or simple regression 
test). Although the study sample is small, we could have some estimates using the simple 
linear regression test to measure some of the study’s results. The study data analyzed 
using Excel spreadsheets and we used a type I error rate (α) of 0.05 for the hypothesis 
tests conducted in this project. 
Results 
1. Participant Demographics 
The study researchers interviewed thirteen cancer health professionals, four males and 
nine females. Their ages ranged from 29-56 years old (Mean=40.85 years old, 
Median=40 years old).  All of the thirteen participants were cancer professionals who 
attended NAACCR-2016 conference. The race of our participants was varied: seven 
Whites, four African-Americans, one Asian, and one Native Hawaiian or other Pacific 
Islander. Three of the subjects hold PhD degrees, six hold master degrees, one bachelor 
holder, one associate degree holder, and only one got some college level education. The 
associate degree and the some college holders were working as certified cancer registrars 
in two separate central cancer registries.  At the time of data collection, the PhD holder 
subjects’ work roles were:  a cancer researcher, an epidemiologist, and a director and 
associate professor. The master degree holders’ work roles were: a program director and 
epidemiologist, a statistical consultant, a research coordinator, a software engineer, a 
cancer surveillance and epidemiologist, and an epidemiologist. The bachelor degree 
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holders were functioning as: a research analyst and public health epidemiologist, and an 
abstractor and quality control manager. The associate degree holder was functioning as a 
certified cancer registrar and the subject who holds some college education was working 
as a data manager in a central cancer registry. The total experience in public health for 
the all subjects ranged between 2 years to 19 years (Average= 10.38 years, Median= 10 
years). The subjects’ total experience in using GIS tools in work was between null 
experience to 10 years (Mean= 2 years, Median= 0 years).  
2. Reports’ Effectiveness and Efficiency 
The Mapping Reports’ Effectiveness 
Effectiveness per Participant 
One of the participants could not complete three successive tasks #4, 5, & 6. The subject 
held a bachelor degree and she did not have any previous experience in using GIS tools 
and interactive mapping reports. Another subject could not get the assigned results for 
two successive tasks #4 & 5. This subject holds a PhD degree and has had experience in 
public health for 15 years, experience in using GIS tools at work, and work as a director 
at one of the central cancer registries. Two of the subjects could not complete two non-
successive tasks: one of these subjects holds master’s degree and could not finish the 
tasks #5 & 8 successfully and another subject holds just some college education missed 
the tasks #4 & 8. The master’s degree subject had experience in public health field for 15 
years and five years of using GIS tools and software, and the some college degree holder 
had experience of 19 years in public health and no previous experience in using or 
reading GIS tools. Four of our subjects could not accomplish just one task and the missed 
tasks were #5, 6, &9. Two of these participants were PhD holders, one master degree 
   157
holder, and a bachelor degree holder. The two PhD holders had experience of 8 and 10 
years in public health field and experience of 4 and 5 years of using GIS tools in their 
daily work. The master degree holder had 17 years of public health experience and no 
previous experience in GIS tools. The bachelor degree holder had experience in public 
health field of 10 years with null experience in using GIS tools.  
Only four of our 13 participants (30.76%) achieved the TCR of 100%. Three of these 
participants were master’s degree holders and one of them held an associate degree in 
science. These four subjects have experience in public health field between two to ten 
years, and all of them carried no previous experience in using GIS tools and interactive 
mapping reports.  Twelve of our 13 participants (92.30%) were able to accomplish the 
tasks with TCR of 79% or above. The only one subject who got TCR of <79% was a PhD 
holder and a director of a central cancer registry with 12 years public health experience 
and null GIS experience.   
The results were ranged from 70% to 100% as Figure (1) shows. 
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Figure 1. Task Completion Rate for All Tasks per Participant.  [Note: Blue Bars Indicates 
Participants Who Finished the Trial with ≥ 78% TCR; Purple Bar Indicates Participants 
Who Finished the Trial with <78% TCR.] 
Effectiveness per Single Task 
The above task completion formula was also used to calculate the task completion rate 
per task of the study’s ten tasks. The results are presented in Figure (2) 
 
Figure 2. Task Completion Rate per Task for All Participants. [Note: Blue Indicates 
Tasks Involving the Area Health Profile (Tasks 1–6); Red Indicates Tasks Involving the 
Double Map (Tasks 7–10)] 
As Figure (2) shows, four tasks (38.46%) reached the 100% completion success rate, one 
task (7.69%) got 90% of the completion success rate, one task (7.69%) got 85% or higher 
completion rate and three tasks (23.08%) got less than 80% of completion success rate. 
The tasks #1, 2, 3, 7, and 10 got TCR of 100%. As the multi-task scenario shows (see the 
appendix), the tasks #1, 2, & 10 had very simple context and functionality. The 
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mentioned tasks do not need to explain or interpret difficult epidemiology or statistical 
outcomes. Task # 3 was ranked as a one of the complicated tasks but it was successfully 
accomplished by all the subjects.  
Task #6 was ranked as one of the complicated tasks, but was accomplished effectively in 
both study rounds. Task #6 was effectively accomplished by the study subjects in the two 
rounds of the study, with completion rate of 100% in the first round and just 85% in the 
second round.  
The tasks #4, 5 & 8 had the lowermost TCRs. These tasks were not effectively conducted 
because the tasks’ TCRs were less than 78%. These tasks were ranked as difficult tasks 
and require certain abilities and understanding to be completed successfully.  Some of 
these tasks are multi-stepping tasks and needs special knowledge to be figured out. From 
the first round of the study, the same tasks in addition to the task # 3 got the lowest 
completion rates.  
Mapping Reports’ Efficiency and Productivity 
The investigators used the audio-video records to measure the time per task which was 
measured from starting the examined task to the time of beginning the next task. The 
median of task #8 was the highest followed by # 4, 5, 6, and 3. This was relatively 
connected to the task’s difficulty. Table (1) shows the times which our subjects spent on 
the study tasks individually. 
 
 
   160
Table 1. Time on the Study Tasks 
Task # Task Time Range Task Time Mean Task Time Median 
1 6-17 seconds 9.77 seconds 7 seconds 
2 6-300 seconds 44.92 seconds 16 seconds 
3 6-114 seconds 28.69 seconds 19 seconds 
4 9-166 seconds 83.38 seconds 113 seconds 
5 12-245 seconds 85 seconds 51 seconds 
6 15-196 seconds 82.62 seconds 78 seconds 
7 6-43 seconds 11.62 seconds 8 seconds 
8 50-429 seconds 182.77 seconds 179 seconds 
9 9-26 seconds 13.75 seconds 12 seconds 
10 3-7 seconds 5.54 seconds 6 seconds 
 
Time Based Efficiency and Overall Relative Efficiency 
The time based efficiency rates were ranged between 0 goals/second for task #8 and 0.12 
goals/second for task #1. Figures (3) and (4) show the time based efficiency and the 
overall relative efficiency for every individual performed tasks. 
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Figure 3. Time-based Efficiency (TBE) per Task 
From Figure (3), the TBE per task was different for the all the tasks. Task #10 gained the 
maximum TBE (.35 Goals/Second) and this result was associated with ease of the task 
(close the map), followed by the tasks #7, 9 and 1 and all of them ranked as simple and 
straight forward tasks (proceed to the “double map” link on the desktop, open the “area 
profile” map link in the desktop, and check the sources of our mapping report data). 
Tasks #5, 6, and 8 got the lowest TBE levels, 0 goals/second for the task #8 and .02 
goals/second for the tasks # 5 & 6. Tasks #5, 6, &8 were ranked as the most complicated 
tasks. 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
1 2 3 4 5 6 7 8 9 10
G
oa
ls
/S
ec
on
d
Task Number
Time-based Efficiency Per Task
   162
 
Figure 4. Overall Relative Efficiency per Task. [Note: Orange Indicates Tasks with 100% 
ORE per Task; Dark Tan Indicates Task with Less Than 100% ORE per Task] 
Figure (4) shows that the highest ORE rates were for the tasks #1, 2, 3, 9& 10 and they 
were categorized as easy tasks except the task #3, which is ranked as a complex task. 
Task #8 got an OTE of 93% in comparison to almost OTE of 90% in the first round. Task 
#6, a ranked complicated task, followed with an OTE of 88% ORE rate, in comparison to 
the OTE of about 95% in the first round. Tasks # 4, 5, & 7 had the lowest ORE per task.  
3. Users’ Satisfaction 
The scale was given to every study subject to be completed at the end of the study 
experiment. This tool was constructed to assess expectations and insights of the users 
regarding the tested systems [16]. Figure 5 presents the study subjects’ SUS scores.  
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Figure 5. System Usability Scale (SUS) Scores of the Study’s Participants. [Note: Brown 
Color Indicates SUS Score of ≥ 68 Points; Blue Color Indicates SUS Score of < 68 
Points] 
SUS scores can be between 0 and 100. As Figure 5 illustrates, the SUS scores for the 
current study’s subjects ranged from 25 to 82.5, with a mean of 58.85 points and median 
of 65 points. Four of our 13 (30.77%) participants had a SUS score of more than 68 
points; the remaining nine subjects (69.23%) did not reach the accepted satisfaction point.  
4. Factors Affect the Participants’ Performance 
Education Level and Work Type Factors 
The researchers conducted Wilcoxon-Mann-Whitney test to explore the statistical 
association among the education level of the participants from one part and the task 
completion rate and the SUS scale for the study subjects.  There was no significant 
statistical difference between the performance of the graduate school degrees holder 
participants and the undergraduate degree or less holder participants (P = .51). The 
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results show that there was no significant statistical relationship between the participants’ 
education level and the satisfaction score of the SUS (P = .16).  
The same inferential test was also used to assess the statistical relationship between the 
participants’ performance on the test in terms of the task completion rate and the work 
type of the same participants as cancer researchers and epidemiologists from one part, 
and participants who do not do research and do not have previous experience in cancer 
epidemiology or surveillance on the other part. The relationship between the studied two 
factors was statistically insignificant (P = .41).  
Experience in Healthcare Field and Experience with Mapping Reports and GIS Tools 
Factors 
A simple regression test was used to search if there is a significant statistical relationship 
between the performances of the study participants in the current usability trial and 
between both: the experience in healthcare field and the previous experience with 
mapping reports and other GIS tools. The statistical relation between the performances of 
the participants in the trial and between the experience in healthcare field was 
insignificant (P = .51).  In the current study, there was no significant statistical 
relationship between the subjects’ performance on the study test and the experience in 
GIS tools (P = .17). 
After we conducted a simple linear regression test, there was no significant statistical 
relationship between the SUS levels and both the experiment completion rate and the 
previous experience with GIS tools for the study participants. The P values for these 
results were (P = .67) and (P = .61) respectively.  
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Table 2. Demographic and Previous Expertise Factors of the Study Participants Versus 
the Trial’s TCR and the Participants’ SUS Scores  
The Studied Factors P 
Education Level Per participant vs 
TCR Per Participant 
.51 
Education Level per Participant vs 
SUS Score Per Participant 
.16 
Work Type Per Participant vs TCR 
Per Participant 
.41 
Previous Experience in Healthcare 
Field Per Participant vs TCR Per 
participant 
.51 
Previous Experience in GIS Use 
Per Participant vs TCR Per 
Participant 
.17 
Previous Experience in GIS Use 
Per Participant vs SUS Score Per 
Participant 
.61 
 
5. Correlation between the Studied Usability Elements (Effectiveness, 
Efficiency, and Satisfaction) 
We measured the correlation between the major three usability elements, effectiveness, 
efficiency, and the satisfaction of the users. The current study revealed the following 
findings: 
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There was a very weak correlation between the task completion rates and the SUS scores 
for the participants (r = .31, P = .31), while the correlation was very high between these 
factors in the first round of the study (r = .7, P = .08).  
The researchers studied the relation between the task completion rates by task from one 
side and both the TBE and the ORE factors. The current study discovered that there were 
strong correlation between the effectiveness and the efficiency usability elements of the 
studied maps and the correlation was: (r = .39, P = .18) and (r = 81, P = <.001). The 
correlation is weaker than the correlation between these factors in the first round of the 
study (r = .50, P = .25), and (r = .92, P = .003).  
The current research also discovered a very strong correlation between the time spent by 
the participants on the given tasks and the study subjects’ satisfaction (r = .92, P = 
<.001). This correlation is stronger than the correlation between the same factors in the 
first round of the study (r = .70, P = 0.07). 
Table 3. Correlation between the Studied Usability Elements (Effectiveness, efficiency, 
and Satisfaction) 
The Studied Factors Correlation 
Coefficient 
P-Value 
TCR vs SUS Score .31 .31 
TCR vs TBE .39 .18 
TCR vs ORE .81 <.001 
Total Time Of The Trial (Efficiency) 
Per Participant vs SUS Score 
.92 <.001 
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Discussion 
Main Findings 
The current study was a second round of a usability testing study was conducted to assess 
usability of the published mapping report of MCR-ARC. This multi-approach usability 
testing methods might aid map creators to design user-friendly mapping reports and help 
them to access the maps’ prospective users’ anticipations. The study findings support 
using usability testing studies before and after releasing the MCR-ARC maps to the 
potential users. 
Participant Demographics 
The researchers conducted this study as a second round of the previous pilot usability 
study on the same tested mapping reports which are published by MCR-ARC. Previous 
study includes seven convenient academic health professionals. The investigators refined 
the tested maps and the usability study’s multi-tasks scenario considering all the 
recommendations and preferences from the first round subjects.  The investigators 
assumed that the first round’s results might be tightly connected to the favorites and the 
insights of the academic health professionals who did not handle cancer data registration 
and/or analysis, did not directly make and advocate for cancer policy, and did not use 
cancer mapping reports in their daily practical life. That is why the investigators tried to 
apply the experiment on the cancer officials who were attending NAACCR-2016 
conference aiming to explore the usability of the refined tested maps using a convenience 
sample of cancer officials.  
Effectiveness and Efficiency 
Effectiveness per Participant 
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In the current study, we are aiming to attain 100% of completion success rate per 
participant, but the usability specialists allocated that for any usability study it is ok to 
consider 78% as the average TCR per participant [21].   
According to the results in Figure (1), the trial was completed effectively by twelve out of 
our 13 participants (92.30%). The trial was conducted effectively despite the diversity in 
the education, public health field experience, or GIS experience of the study subjects. A 
PhD holder subject with a heavy cancer and public field experience could not accomplish 
the minimum border of the accepted TCR, while the other lower educated and less 
experienced subjects could handle the test effectively. 
Effectiveness per Task 
As the results section shows, the ranked easy tasks were accomplished more effectively 
than the tasks ranked as complicated. These findings supported the first round study and a 
previous scientific article’s results, which revealed that tasks accomplishments are 
influenced by the task context’s complexity [24]. 
Surprisingly, task #6 was graded as one of the complex tasks but was conducted 
successfully in both study rounds. In this study round, it could be explained that because 
the task is very linked to the prior tasks and it was easy to handle after the subject solve 
the former tasks. The variance in TCRs per task between the two rounds of study might 
be interpreted as following: The second round’s participants’ educational backgrounds 
were very diverse and not all of them had solid epidemiological and/or statistical 
background that the first round participants hold. 
   169
Efficiency  
As in the first round of the study, there was difference in the time per task even with the 
TCR of 100%. The study subjects in the two study rounds spent various time to 
accomplish the given tasks. As we revealed from the first round of the study, these 
findings were relatively related to the complexity of the tasks, where the complex tasks 
took longer than the easy tasks.  
Also as we revealed from the first round, this round of study discovered that even the 
simply ranked tasks, some of the subjects consumed longer time to accomplish the tasks 
effectively than the other subjects. These results are unpredictable because, as we 
discussed previously, the study investigators adjusted the tested maps according to the 
first round subjects’ comments. Based on the TBE results from the previous study round 
and the current one, the investigators expected that in addition to the intellect and 
knowledge which are essential to achieve these tasks. The usability problems also could 
even make the given tasks more difficult than the study researchers assumed before they 
started the study. For both study rounds, we revealed that OTEs for most tasks were fairly 
related to the difficulty of these tasks’ context, and this supports the previous usability 
literature findings [22]. But surprisingly, this is inapplicable for the previously ranked 
complicated tasks, #3, 6 & 8. After close scrutiny of the recordings, we discovered that 
the repeatability and re-doing of the preceding tasks profoundly influenced the tasks #3, 6 
and 8 completions by the study subjects in both study rounds.   
Participant’s Satisfaction 
Sixty eight points or more has been considered satisfactory according to usability 
literature and advanced marks through 100 points exemplify the optimal to greatest SUS 
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score. In comparison to the first round of the study, we found that both rounds have an 
average and the medians measures of less than 68 points and were close to each other.  
Our explanation to the comparability of the satisfaction results between both study rounds 
is that in the second round, we tested cancer professionals of more varied races and with 
mixed graduate and undergraduate levels and most of these participants had null previous 
experience in using GIS. These participants developed a comparable satisfaction results 
as the first round study’s subjects, who were holding graduate degrees and had rich 
experience in statistical and epidemiological knowledge, as well as previous experience 
in using GIS tools. We assumed that, when we updated our maps according to the first 
round’s results, we simplified our tested maps to fit the needs of our potential users of 
different biographic and experience levels.  
Usability scholars revealed that the users’ insights and anticipations are critical to 
building faultless technology. Considering all the users’ commentaries are essential to 
make the technology more satisfactory and useful [24]. We considered the participants’ 
texts which were taken at the end of every trial, in addition to the audio-visual records of 
all the participants to explore more usability issues of the tested maps. The revealed 
usability issues helped us to explain and find out why some of the assigned study tasks 
were hard to be handled by the highly educated and knowledgeable subjects. The study 
researchers considered all of the discovered usability problems, and accordingly, will 
refine our published mapping reports and publicize them on the registry’s website.  
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Factors Affect the Participants’ Performance 
There weren’t significant statistical relationships between all the studied factors. While 
there was a significant statistical relationship between TCR rates and the previous 
experience in using GIS tools in the first round of the study, in this round, there is no 
significant statistical relationship between these two factors. The current study’s finding 
might be explained as following: By considering the round one’s results and by updating 
our maps, we made the tested maps simpler to be used by the subjects who had null 
experience in using GIS technology. Both study rounds revealed that there is no 
dependency of the SUS score on the both the TCR and the previous experience with GIS 
tools for the study participants as the investigators assumed. 
The Correlation between the Studied Usability Elements (Effectiveness, Efficiency, 
and Satisfaction) 
The results revealed positive correlation between the three usability elements which 
range from very weak to very strong positive correlations. The strong correlation between 
the SUS and the efficiency is very reasonable, and this supports the findings of the 
previous round. This could be explained that by updating the maps, we made the maps 
more usable by the users, and the participants conducted the trial more efficiently and 
they were satisfied about the entire experience. 
Strength and Limitation of the Study 
This study is the second round of the usability research conducted on the published 
MCR-ARC InstantAtlas™ mapping reports to evaluate the quantitative and qualitative 
measurements using a larger sample than we used for the first round. The investigators 
used a sample of 13 participants who are professionals in cancer epidemiology, cancer 
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surveillance and/or cancer research. We are assuming that the second round professional 
participants will be the potential users of the interactive mapping reports rather than the 
academia people who had been selected for the first round trial. Larger sample of cancer 
professionals and testing the modified reports based on the first round’s findings, make 
this round more reasonable and the results tend to be more applicable.  These results 
might be generalized to assess the usability and the functionality of all the MCR-ARC’s 
mapping reports.   
There are several limitations for the study. The sampling technique was the convenience 
sampling method. The methodology might not determine all the detailed performance and 
behavioral usability metrics of the participants. The audio-video records were analyzed 
manually by the primary investigator. We might also think of introducing more 
sophisticated methodology using advanced usability software, for example, advanced 
usability software and/or Eye Tracking software to record and analyze our usability data.  
Future Directions and Recommendations  
We are recommending conducting usability testing pilots on all current and the future 
designed mapping reports by the MCR-ARC.  Also, we are targeting that usability 
assessment should begin from the planning procedure, map release, and after 
dissemination the mapping reports by using a representative sample of these maps’ 
probable users to precisely assess the usability of these maps. Additionally, we are 
hoping that we could use more advanced usability tools in future to evaluate our released 
maps.  
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Conclusion 
Current round of the study measured the three main components of the refined tested 
mapping reports: effectiveness, efficiency, and user satisfaction. The study results 
supported the first round’s findings that the three usability elements are correlated 
positively to each other. As we revealed from the previous round, the examined reports’ 
effectiveness results were superior in comparison to the efficiency and satisfaction 
results. As we pointed out from the first round, we revealed that the effectiveness and 
efficiency metrics were strongly associated with the trial tasks context’s complexity. As 
we concluded in the previous study, the graded simple tasks were achieved more 
effectively and more efficiently than the graded complicated tasks. The SUS scores of the 
current study round were comparable to the previous round study’s SUS scores with a 
poor average and median while the SUS score ranges of the both studies were ranged 
from very poor to excellent scores.    
The current study, as opposed to the previous round, showed that there was no significant 
statistical relationship between the subjects’ performance on the study test and having 
previous experience in using the GIS tools. We explained this finding that, by updating 
the tested maps and tasks, we made the reports simpler to be used even by users who do 
not have previous GIS experience. As we learned from the previous round of the study, 
the researchers did not reveal any significant statistical relationship between all the 
studied factors.  
As we concluded previously from the first round, we learned that the pretest 
questionnaire and the multitask scenario are not enough to reveal all the usability 
problems of the examined mapping reports. Also, we concluded that pursuing users’ text 
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remarks closely investigating the audio-video records are very treasured in discovering 
more usability issues and exploring the users’ favorites and perceptions towards GIS 
technology.  
We concluded that the examined mapping reports must be extensively refined and 
modified to correct all the revealed usability concerns and to meet the perceptions and 
requirements of the maps’ potential users.  
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Appendix A: Creation of the Senate District Population File (2008-2012) 
For the fourteen (14) districts that are aggregations of counties, the district population is 
simply the aggregation of the age, race, year, and sex populations of the corresponding counties. 
For the remaining twenty (20) districts with boundaries that do not follow county boundaries, the 
population file was constructed with the following process:  
1. A set of twenty (20) senate district groupings we termed “senate district grouped 
to county boundaries” (SDGCs) were created that minimally aggregated the 
districts to follow county boundaries. The 20 SDGCs are each of the 14 districts 
that originally followed county boundaries along with the following six (6) 
aggregated regions: 8 districts of Franklin County, St. Louis City, and St. Louis 
County; 2 districts of St. Charles County; 2 districts covering 6 counties south of 
St. Louis; 4 districts of Jackson County; 2 districts covering 15 counties in 
northwest Missouri; and 2 districts covering Christian and Greene counties). 
2. The county-level population file obtained via the SEER program was aggregated 
in to the 20 SDGCs created in step 1 for each of the age (19 groups), bridged 
single-race, year, and sex groupings. 
3. Non-annual, but senate district level, population counts by age, race, and sex 
were created by the following steps: 
a. The following senate-district-level, sex-by-age, 2009-2013 Census 
American Community (ACS) tables were downloaded: B01001 (all races 
combined) and B01001A-B01001E (white alone, African-American 
alone, American Indian/ American Native) AI/AN alone, Asian alone, 
Native Hawaiian or Other Pacific Islander (NH/OPI) alone. 
b. The all races combined ACS populations (which were mostly in 5-year 
groupings except for extra breaks in the late teens/early twenties and 
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retirement age, and all ages over 85 were grouped) were aggregated into 
18 groups of 5-years with 85+. 
c. The race-specific ACS populations (which had 5-year groupings under 
age 35 except with a break age at 18, 10-year groupings over the age 35, 
and all ages over 85 were grouped) were aggregated into 13 groups by 
collapsing the break at age 18. 
d. Separately for each sex, race-specific populations in 18 groups were 
estimated by splitting the 10-year spans in the ACS race-specific 
population into the two 5-year spans by allocating the population 
proportional to the all races combined ACS population. 
e. The Asian alone and NH/OPI alone 18 age-group populations were 
added together to create an Asian/Pacific Islander (A/PI) population file. 
4. For each sex and the 4 races (white alone, African-American alone, AI/AN alone, 
and A/PI), the 18 age-group senate-district-level populations were aggregated 
into the 20 SDGCs created in step 1. 
5. Proportions allocating SGD populations to senate districts were computed with 
the following steps: 
a. For each age (18 groups), race (4 groups), sex, and SDGC combination: 
the proportion of the population within each of the contained senate 
district was computed. 
b. Population proportions in 19 groups were approximated by letting both 
the proportions for <1 year-olds and the proportions of 1-4 year-olds be 
equal to the proportions of 0-4 year-olds for each race, sex, and SDGC 
combination. 
6. Finally, the proportions computed in step 5 were applied to the SEER population 
file aggregated in step 2 to allocate the SDGC populations to each contained 
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senate district by age (19 groups), race, year, and sex. Here, the bridged single-
race groupings of the SEER population file were approximated with the race-
alone groupings originating from the ACS population files. 
*Hispanic ethnicity was not considered during the construction of this population file. 
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Appendix B: Usability Testing Questionnaire 
Pre-Trial Questionnaire 
Participant # 
Age: 
Gender:  Female ……                         Male ……                         Other …… 
Race: 
 American Indian or Alaskan Native …… 
 Asian …… 
 African-American …… 
 Native Hawaiian or Other Pacific Islander …… 
 White …… 
Other …… 
Education level: 
………………………………………………………………………………………… 
Employment role (work type): 
………………………………………………………………………………………… 
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Institution name: 
………………………………………………………………………………………… 
Total experience in public health field: 
………………………………………………………………………………………… 
………………………………………………………………………………………… 
Total experience in using GIS interactive reports in work: 
………………………………………………………………………………………… 
………………………………………………………………………………………… 
…………………………………………………………………………………………
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Appendix C: Multi-task Test Scenario 
Multi-task Usability Testing 
Task (1): 
 Open the “Area Health Profile” link on the desktop 
Task (2): 
 Open “Choose Map Data” 
Task (3): 
 Choose the age-adjusted incidence rates for Female Breast 55+ for 2008-2012 
Task (4): 
 Write down the incidence rate and the 95% confidence interval (CI) for Boone 
County 
 Rate: …………….……                Confidence Interval 
(CI)……………................…… 
Task (5): 
Was the rate statistically significantly higher, lower, or no different from the 
statewide rate? 
 …………………………… 
Task (6): 
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 What is the bar graph on the right side representing? 
 ………………………………………………………………………………………
… 
………………………………………………………………………………………
… 
Task (7): 
 Proceed to the “Double Map” link on the desktop 
Task (8): 
 Subtask I: 
Choose the age-adjusted incidence rates for Female Breast 40+ indicator for 
2003-2012 as indicator 1 
Subtask II: 
Choose Age adjusted incidence for Lung and bronchus indicator for 2003-2012 as 
indicator 2 
Subtask III: 
Write down the correlation coefficient and the regression equation 
Correlation coefficient: ……………                              
Regression equation:  ……………………………………………. 
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Task (9): 
 Check the sources of our mapping report data 
Task (10): 
 Close the map  
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Appendix D: SUS Scale for Testing MCR-ARC Mapping Reports 
System Usability Scale 
© Digital Equipment Corporation, 1986. 
      Strongly disagree                                                        Strongly agree 
1. I think that I would like to use 
this interactive mapping report 
frequently 
 
 
2. I found the mapping report 
unnecessarily complex 
 
 
 
3. I thought the mapping report 
was easy to use 
 
 
4. I think that I would need the 
support of a technical person 
to be able to use this mapping 
report  
 
5. I found the various functions 
in this mapping report were 
well integrated 
 
6. I thought there was too much 
inconsistency in this mapping 
report 
 
 
7. I would imagine that most 
people would learn to use this 
mapping report very quickly 
 
 
8. I found the mapping report 
very cumbersome to use 
 
 
9. I felt very confident using the 
mapping report 
 
10. I needed to learn a lot of things 
before I could get going with 
this mapping report 
    
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
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Appendix E: Usability Trial’s Recruitment Email 
Invitation to Participate in a Usability Testing Study 
Dear Health Professional; 
We are asking you to participate in a research study that is IRB approved.  This study will 
investigate the usability of the published interactive mapping reports of the Missouri 
Cancer Registry and Research Center MCR-ARC. 
If you chose to participate, the Principal Investigator (PI) will interview you.  The testing 
session will last about 20 minutes and your face and other body parts will not be 
recorded.  
How do I sign up? 
Simply send an email to the following email address (aab365@mail.missouri.edu), and 
we will set up a 20 minutes appointment. The PI, Awatef Ben Ramadan, will handle it 
from there. We will arrange to meet you in a private and confident space to conduct the 
trial during the conference period. 
The study investigators: 
1. Awatef Ahmed Ben Ramadan, MD, MPH 
Graduate Research Assistant at MCR-ARC and HMI Department  
2. Jeannette Jackson-Thompson, MSPH, PhD 
Director, Missouri Cancer Registry and Research Center 
Research Associate Professor, Health Management & Informatics 
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University of Missouri School of Medicine  
3. Chester Lee Schmaltz, PhD 
Senior Statistician, Missouri Cancer Registry and Research Center 
Teaching Professor, Department of Health Management and Informatics 
University of Missouri School of Medicine 
 
Please do not hesitate to contact us on aab365@mail.missouri.edu or call me at 
(573) ***-**** 
Thank you very much 
                              Awatef Ahmed Ben Ramadan, MD, MPH 
                                                            PhD Student - University Missouri Informatics 
Institute (MUII) 
                                     GRA at Missouri Cancer Registry (MCR-ARC) 
               University of Missouri, Columbia 
                                                                      aab365@mail.missouri.edu 
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